methotrexate has been researched along with Disease Models, Animal in 358 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 66 (18.44) | 18.7374 |
1990's | 29 (8.10) | 18.2507 |
2000's | 61 (17.04) | 29.6817 |
2010's | 157 (43.85) | 24.3611 |
2020's | 45 (12.57) | 2.80 |
Authors | Studies |
---|---|
Brattsand, R; Fyfe, M; Graffner-Nordberg, M; Hallberg, A; Mellgård, B | 1 |
Hori, S; Kikkawa, T; Mori, S; Ohtsuki, S; Otagiri, M; Takanaga, H; Terasaki, T | 1 |
Al-Shamma, H; Barden, J; Buzard, DJ; Calderon, I; Chen, C; Edwards, J; Espinola, S; Fu, L; Gao, Y; Gatlin, J; Gharbaoui, T; Han, S; Jones, RM; Kawasaki, A; Krishnan, A; Le, M; Lehmann, J; Liu, L; Lopez, L; Moody, J; Morgan, M; Sadeque, A; Sengupta, D; Solomon, M; Thatte, J; Thoresen, L; Ullman, B; Usmani, K; Whelan, K; Xing, C; Zhu, X | 1 |
Bailey-Downs, LC; Gangjee, A; Ihnat, MA; Namjoshi, OA; Thorpe, JE; Yu, J | 1 |
Alonso-Castro, AJ; Campos-Xolalpa, N; Hernández-Munive, A; Pérez-González, C; Pérez-Gutiérrez, S; Zapata-Morales, JR | 1 |
Bhide, RS; Carter, PH; Davies, P; Dhar, TG; Goldstine, CB; Gu, X; Neels, J; Pedicord, DL; Poss, MA; Qin, LY; Ruan, Z; Ruepp, S; Sack, JS; Salter-Cid, LM; Skala, S; Stachura, S; Stefanski, K; Weigelt, C; Xie, JH | 1 |
Cai, HD; Chen, ZH; Fang, MH; Huang, HH; Su, YP; Xu, Y; Yang, J; Yu, CX; Zeng, YL | 1 |
Adile, AA; Bakhshinyan, D; Berger-Becvar, A; de Araujo, ED; Deininger, MW; Fishel, ML; Gawel, JM; Geletu, M; Grimard, ML; Gunning, PT; Heaton, WL; Konieczny, SF; Luchman, HA; O'Hare, T; Raouf, YS; Shah, F; Shouksmith, AE; Singh, SK; Venugopal, C; Weiss, S | 1 |
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
Clausen, MH; Peiró Cadahía, J; Petrovic, K; Previtali, V; Troelsen, NS | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Artigas, A; Blanch, L; Bringué, J; Camprubí-Rimblas, M; Guillamat-Prats, R; Martinez, ML; Torrents, E | 1 |
Abdel-Moneim, AM; Alfwuaires, M; Alzahrani, AM; Elsawy, H; Khalil, M | 1 |
Ahmed-Farid, OA; Bakeer, RM; Hashad, IM; Mansour, DF; Rady, M; Saleh, DO | 1 |
Aranarochana, A; Chaisawang, P; Naewla, S; Pannangrong, W; Sirichoat, A; Sritawan, N; Suwannakot, K; Welbat, JU; Wigmore, P | 1 |
Li, S; Shi, J; Tang, H | 1 |
Fukuo, Y; Futamura, G; Hiramatsu, R; Hu, N; Kashiwagi, H; Kawabata, S; Miyatake, SI; Suzuki, M; Takata, T; Takeuchi, K; Tanaka, H; Wanibuchi, M; Watanabe, T; Yoshimura, K | 1 |
Abd El-Aal, SA; Arab, HH; Arafa, EA; Ashour, AM; Eid, AH; Mahmoud, AM | 1 |
Baker, K; Cole, PD; Diglio, F; Li, S; Marshall, G; Patel, C; Wen, J | 1 |
Aldossary, SA; Chohan, MS; Mohaini, MA; Tasleem Rasool, S | 1 |
Aoki, Y; Bouvet, M; Hamada, K; Han, Q; Hoffman, RM; Kubota, Y; Masaki, N; Nishida, K; Tome, Y; Yamamoto, J | 1 |
Alqahtani, SS; Alshahrani, S; Banji, D; Banji, OJF; Rashida, S | 1 |
Agostini, SBN; Alves, CO; Bernardes, MTCP; Carvalho, FC; da Silva, LP; Gonçalves, RV; Novaes, RD; Pereira, GR | 1 |
Amada, N; Futamura, T; Kakumoto, Y; Maeda, K | 1 |
Kim, HJ; Kim, MA; Lee, CM; Lee, JS; Shin, SR | 1 |
Acharya, AP; Mangal, JL; Suresh, AP; Swaminathan, SJ; Thumsi, A | 1 |
Ikeda, Y; Kajiyama, H; Niimi, K; Nishiko, Y; Nishino, K; Oda, Y; Shibata, M; Shimizu, Y; Tamauchi, S; Yamamoto, E; Yasui, Y; Yokoi, A; Yoshida, K; Yoshihara, M; Yoshikawa, N | 1 |
Bahramizadeh, M; Esmaily, H; Golmohammadzadeh, S; Hatamipour, M; Jafari, MR; Jafarian, AH; Kiafar, B; Moosavian, SA; Nikpoor, AR; Rezaeemehr, Z | 1 |
Aggarwal, G; Chandra, A; Manchanda, S; Narula, A | 1 |
Akturan, S; Cimen, FK; Kurt, N; Malkoc, İ; Mammadov, R; Suleyman, B; Suleyman, Z | 1 |
Chen, YC; Hsiao, CC; Hsu, MH; Huang, LT; Sheen, JM; Wang, SC | 1 |
Du, H; Lan, J; Li, Y; Liu, P; Tao, J; Zhang, L; Zhu, J | 1 |
Alexander, T; Allen, AR; Anderson, JE; Groves, T; Kiffer, F; McElroy, T; Trujillo, M | 1 |
Akdis, CA; Boyman, O; Hafner, J; Impellizzieri, D; Kolios, AGA; Kurzbach, D; Nguyen, TT; Nilsson, J; Özcan, A; Sahin, D; Tan, G; Yawalkar, N | 1 |
Bai, T; Dai, X; Guo, Z; Li, Y; Lu, Q; Tian, X; Yao, J; Zhang, Y; Zhong, Y | 1 |
Furukawa, H; Higuchi, T; Mizuno, S; Naito, T; Oka, S; Ono, M; Takahashi, S; Tanaka, K; Tohma, S; Tsuchiya, N; Warabi, E; Yoshimura, M; Yuhara, S | 1 |
Li, H; Li, X; Liu, J; Luo, S; Wan, Z; Wang, Y; Wu, X; Xie, X; Yang, M; Zhao, Z | 1 |
Abdelazem, AZ; Abdelaziz, RM; Attia, YA; Hashem, KS | 1 |
Berlin, C; Hopland, K; Lange, K; Lekaye, HC; Phillips, S; Piao, J; Tabar, V | 1 |
Bai, J; Fan, X; Hu, J; Hu, M; Li, Y; Sun, Y; Wang, B; Xu, Y; Zhao, S | 1 |
Abd-Elhalem, SS; Abu-El Magd, EE; El Zawawy, WK; El-Shinnawy, NA; Haggag, NZ | 1 |
Muhammad, N; Rizvi, SAA; Saleh, AM; Shahzad, Y | 1 |
Abdel-Moneim, AM; Alfwuaires, M; Algefare, AI; Elmenshawy, OM; Elsawy, H; Khalil, M; Sedky, A | 1 |
Aldhahrani, A; Alkhedaide, A; Althobaiti, F; Mohamed, WA; Nassan, MA; Soliman, MM | 1 |
Gao, Y; Huang, B; Jin, X; Liang, X; Liu, Y; Lv, J; Ma, J; Tang, K; Tong, W; Wang, J; Wang, X; Xie, J; Xu, P; Yao, F; Zhang, H; Zhang, Y; Zhou, N | 1 |
Chaisawang, P; Pannangrong, W; Prajit, R; Sirichoat, A; Sritawan, N; Welbat, JU; Wigmore, P | 1 |
Abdel-Wahab, BA; Ali, FEM; Alkahtani, SA; Alshabi, AM; Hassanein, EHM; Mahnashi, MH | 1 |
Chen, Y; Dai, Z; Han, L; Huang, RY; Liang, CL; Liu, H; Lu, C; Qiu, F; Yan, Y; Zhang, Q | 1 |
Hamaue, N; Hirafuji, M; Iizuka, K; Kikuchi, K; Machida, T; Minami, M | 1 |
Ayhan, A; Benkhoff, M; Dannenberg, L; Helten, C; Huhn-Wientgen, R; Ignatov, D; Kelm, M; Levkau, B; M'Pembele, R; Mourikis, P; Petzold, T; Polzin, A; Sarabhai, T; Trojovsky, K; Zako, S; Zeus, T | 1 |
Bergamo, M; Häfeli, UO; Nosrati, Z; Rodríguez-Rodríguez, C; Saatchi, K | 1 |
Fu, G; Gu, X; Hou, J; Liu, X; Shi, C; Sun, Y; Tian, J; Wu, J; Yu, B; Zhang, M; Zhang, R; Zheng, Y | 1 |
Anger-Góra, N; Goszczyński, TM; Mierzejewska, J; Pajtasz-Piasecka, E; Rossowska, J; Świtalska, M; Szczygieł, A; Węgierek-Ciura, K | 1 |
Abdelhamid Ibrahim, SS; Ali, MA; El-Sayyad, SM; Kandil, LS; Ragab, GM | 1 |
Agrawal, S; Gamian, A; Hamar, P; Krawczyk, M; Krenács, T; Makuch, S; Pastuch-Gawołek, G; Szeja, W; Szkudlarek, D; Wiśniewski, J; Woźniak, M | 1 |
Akselim, B; Gulaboglu, M; Kiremitli, S; Kiremitli, T; Mammadov, R; Tor, IH; Yazici, GN; Yilmaz, B | 1 |
Gao, J; Han, J; Liu, S; Liu, Y; Ma, D; Su, Y; Tian, M; Wei, C; Xu, K; Zhang, G; Zhang, L | 1 |
Asenso, J; Sun, W; Tang, H; Wang, B; Wang, C; Wang, Y; Wei, X; Wu, Y; Xiao, F | 1 |
Aslan, K; Azizoglu, ZB; Deniz, K; Erdem, S; Haliloglu, Y; Karakukcu, M; Patiroglu, T; Per, S; Suna, PA; Tasdemir, A; Unal, E; Yay, AH; Yilmaz, E | 1 |
Arpag, H; Atilla, N; Aydemir, Y; Cakir, T; Gül, M; Polat, C; Sayan, M; Yiğitcan, B; Þehirli, Ö | 1 |
Alim, MA; Bird, G; Haleagrahara, N; Hayes, L; Ketheesan, N; Miranda-Hernandez, S | 1 |
Barbieri, LR; Carvalho, PO; Gutierrez, PS; Lourenço-Filho, DD; Maranhão, RC; Stolf, NAG; Tavares, ER | 1 |
Han, Y; Hu, S; Sun, W; Wang, L; Wang, Q; Wang, R; Wang, X; Wei, W; Wu, L; Wu, Y; Zhang, L; Zhang, M | 1 |
Fruman, DA; Khaw, A; Konopleva, M; Lee, JS; Lu, M; Lui, B; Mallya, S; Müschen, M; Nguyen, D; Pandori, W; Vo, TT | 1 |
Abbasi, MM; Abdal, K; Abdollahi, B; Aghbali, AA; Fotohi, S; Hamishehkar, H; Khiavi, MM; Salehi, R; Sina, M | 1 |
Obmińska-Mrukowicz, B; Suszko, A | 1 |
Badinter, F; Benhar, I; Goltsman, H; Krispel, S; Liran, A; Miari, R; Neil, GA; Panet, A; Shapir, N; Shatil, T; Sherbo, S; Tal, O; Zafir-Lavie, I | 1 |
Hao, J; Hou, Y; Lin, C; Qian, K; Setrerrahmane, S; Wu, Q; Wu, X; Xu, H; Yu, L | 1 |
Cheng, X; Lee, RJ; Li, Y; Liu, J; Sun, F; Teng, L; Yu, C; Zhang, X; Zhao, J; Zhao, M | 1 |
Boucau, MC; Forsberg, MM; Gosselet, F; Gynther, M; Ihalainen, J; Kanninen, KM; Koistinaho, J; Malm, T; Picardat, T; Ruponen, M; Vellonen, KS; White, AR | 1 |
Panonnummal, R; Sabitha, M | 1 |
Dolatshahi, M; Esmaeilizadeh, M; Goudarzi, M; Hosseinzadeh, A; Khadem Haghighian, H; Mehrzadi, S; Nesari, A; Safaei, F | 1 |
Ferguson, PJ; Girschick, HJ; Hedrich, CM; Hofmann, SR; Kapplusch, F; Morbach, H; Pablik, J | 1 |
Berman, H; Binns, MA; Henkelman, M; Nguyen, M; Piquette-Miller, M; Sekeres, MJ; Tannock, IF; van Eede, M; Winocur, G; Wojtowicz, JM; Yu, J; Zhang, H | 1 |
Al-Melhim, WN; Fouad, AA | 1 |
Fuller, S; Ghanbari, HA; Jiang, ZG; Shevtsova, O; Winocur, G; Wojtowicz, JM | 1 |
Brownfoot, F; Campbell, L; Ellett, L; Hannan, NJ; Hastie, R; Horne, AW; Kaitu'u-Lino, TJ; Lim, E; Sluka, P; Tong, S | 1 |
Bonazzi, A; Caselli, G; Colovic, M; Comi, E; Di Luccio, E; Ferioli, C; Ferrari, F; Giambelli, R; Lanza, M; Letari, O; Maggioni, D; Mennuni, L; Perrella, M; Persiani, S; Piepoli, T; Rovati, LC; Zanelli, T; Zerbi, S | 1 |
Bakhshayesh, M; Goudarzi, M; Kalantari, H; Malayeri, AR; Mehrabani, M; Mehrzadi, S | 1 |
Epete, MA; Famurewa, AC; Folawiyo, AM; Igwe, EC; Maduagwuna, EK; Okike, PI | 1 |
Zhang, H; Zhao, G | 1 |
Carvalho, PO; Gomes, FLT; Hatab, SA; Higuchi, ML; Kalil-Filho, R; Maranhão, RC; Mattos, FR; Pitta, FG; Serrano, CV; Tavares, ER | 1 |
Benko, M; Bismuth, G; Blüml, S; Burkard, TR; Cavaco-Paulo, A; Charvet, C; Feuillet, V; Fischer, MB; Huppa, JB; Lager, F; Le Roux, D; Leksa, V; Machacek, C; Matsuyama, T; Mitulovic, G; Ohradanova-Repic, A; Platzer, R; Renault, G; Stockinger, H; Suchanek, M; Zlabinger, GJ | 1 |
Brands, R; Chandrupatla, DMSH; Elshof, E; Hammond, A; Jansen, G; Lammertsma, AA; Low, PS; Matsuyama, T; Molthoff, CFM; Musters, RJP; Ritsema, WIGR; van der Laken, CJ; Vos, R; Windhorst, AD | 1 |
Allez, M; Bitoun, S; Dönnes, P; Florence, K; Gleizes, A; Hacein-Bey-Abina, S; Hincelin-Mery, A; Krzysiek, R; Le Grand, R; Ly, B; Mackay, F; Mariette, X; Nocturne, G; Pallardy, M; Paoletti, A; Pascaud, J; Pruvost, A; Roques, P | 1 |
Al-Anazi, KM; Allam, AA; Farah, MA; Germoush, MO; Mahmoud, AH; Mahmoud, AM | 1 |
Bai, D; Chen, S; Fan, Y; Huang, R; Lu, L; Shu, Y; Tian, Y; Wang, P; Wang, Y; Wu, L; Xia, X; Xu, H; Yang, L; Yu, C; Yuan, F; Zhang, R; Zhang, S; Zhang, X; Zhou, B | 1 |
Giacomelli, R; Ruscitti, P; Shoenfeld, Y | 1 |
Barres, BA; Geraghty, AC; Gibson, EM; Goldstein, AK; Greene, JJ; Liddelow, S; Monje, M; Nagaraja, S; Ni, L; Ocampo, A; Pallegar, PN; Tam, LT; Vogel, H; Woo, PJ; Wood, LS | 1 |
Akatli, AN; Huz, M; Ozhan, O; Pamukcu, E; Parlakpinar, H; Samdanci, ET; Tanbek, K | 1 |
Chen, L; Duan, L; Fan, J; Guo, M; Hu, G; Huang, Q; Jin, Y; Li, Y; Liao, T; Liao, X; Liu, B; Liu, S; Lv, Z; Tang, K; Tao, X; Wang, X; Wu, F; Xu, J; Xu, P; Yang, G; Zhang, S; Zhou, M | 1 |
Guo, R; Ke, S; Lin, M; Su, Z; Zeng, D | 1 |
Di, T; Li, N; Li, P; Li, X; Liu, Z; Meng, Y; Wang, M; Xie, X; Zhai, C; Zhang, L | 1 |
Ridker, PM | 1 |
Azzoni, P; Benassi, L; Bessar, H; Bianchi, L; Botti, E; Casagrande, V; Costanzo, A; Federici, M; Fratoddi, I; Magnoni, C; Pellacani, G; Samir, MA; Vaschieri, C; Venditti, I | 1 |
Afroz, S; Khan, RA; Siddiqui, DE | 1 |
Feng, L; Guo, M; Huang, W; Kong, L; Shao, F; Song, P; Wu, X; Xu, F; Xu, L; Xu, Q | 1 |
Fawzy, HM; Gad, AM; Kamel, KM; Mansour, SM; Safar, MM | 1 |
Becker, ML; Funk, RS; Kiptoo, P; Siahaan, TJ; Singh, RK; van Haandel, L | 1 |
Gao, Y; Ge, W; Lu, W; Sun, Q; Xu, X; Yang, X; Yang, Y; Zhang, J; Zhao, Y | 1 |
Geraghty, AC; Ghanem, RA; Gibson, EM; Goldstein, AK; Greenberg, ME; Greene, JJ; Longo, FM; Marton, RM; Monje, M; Ni, L; Ocampo, A; Paşca, SP; Yang, T | 1 |
Farombi, EO; Ochaoga, SE; Odunola, OA; Owumi, SE | 1 |
Bolok, Y; Brunengraber, H; Hoppe, G; McCollum, L; Sears, JE; Sharma, A; Singh, C; Song, W; Tran, V | 1 |
Kuyucu, Y; Ozcan, AA; Ozgun, H; Ozkan, EB; Polat, S; Sekeroglu, HT | 1 |
Cabezas-Herrera, J; Fernández-Pérez, MP; Montenegro, MF; Piñero-Madrona, A; Rodríguez-López, JN; Sáez-Ayala, M; Sánchez-del-Campo, L | 1 |
Bhinder, B; Djaballah, H; Fischer, MA; Früh, K; Hirsch, AJ; Nelson, JA; Parkins, C; Radu, C; Shum, D; Smith, JL; Stein, DA | 1 |
Guan, T; Guan, Z; Li, G; Niu, B; Wang, J; Wang, M; Wang, X; Xiang, Q; Xie, Q; Zhang, T; Zhu, Z | 1 |
Deng, ZB; Dryden, G; Guo, H; Jiang, H; Miller, D; Mu, J; Wang, B; Wang, Q; Xiang, X; Yan, J; Zhang, HG; Zhang, L; Zhuang, X | 1 |
Chen, W; Herrero, LJ; Mahalingam, S; Rulli, NE; Sheng, KC; Taylor, A | 1 |
Jie, J; Liu, Z; Tian, B; Yang, Y; Zhang, X; Zhou, M | 1 |
Ahmed, RS; Arora, VK; Banerjee, BD; Subramaneyaan, M; Tripathi, AK; Yasmeen, S | 1 |
Garg, T; Goyal, AK; Parnami, N; Rath, G | 1 |
Bateman, E; Bowen, J; Greenberg, N; Keefe, D; Mayo, B; Plews, E; Schiffrin, E; Stringer, A; Wignall, A | 1 |
Aziz, M; Belmonte, L; Beutheu, S; Bôle-Feysot, C; Coëffier, M; Déchelotte, P; Galas, L; Guérin, C; Ouelaa, W; Tennoune, N | 1 |
Gupta, A; Singh, S | 1 |
Abraham, P; Isaac, B; Kolli, VK; Natarajan, K; Selvakumar, D | 1 |
Aksun, S; Cetin, ES; Dirican, A; Dirican, N; Kalemci, S; Karacam, V; Sözen, H; Sütcü, R; Ulger, E; Uner, AG; Yaylali, A | 1 |
Guan, T; Guan, Z; Guo, J; Li, G; Niu, B; Wang, F; Wang, G; Wang, J; Wang, M; Wang, X; Xiang, Q; Xie, Q; Zhang, T; Zhang, Z; Zhu, Z | 1 |
Cavalcanti, SC; Corrêa, L; Luz, JG; Mello, SB | 1 |
Choi, K; Choi, SJ; Kim, HS; Kim, K; Kwon, IC; Lee, A; Park, K; Seo, DH; Yoon, SY; Youn, I | 1 |
DuHadaway, JB; Gilmour, S; Mandik-Nayak, L; Muller, AJ; Pigott, E; Prendergast, GC | 1 |
Anumol, T; Canet, MJ; Cherrington, NJ; Clarke, JD; Goedken, MJ; Hardwick, RN; Lake, AD; Merrell, MD; Snyder, SA; Street, SM | 1 |
Akbulut, S; Dogan, Z; Elbe, H; Erdemli, E; Eris, C; Otan, E; Toprak, G; Turkoz, Y | 1 |
Cherrington, NJ; Coen, M; Goedken, MJ; Hardwick, RN; Holmes, E; Jin, Z; Kyriakides, M | 1 |
Jost-Brinkmann, PG; Meyer, P; Minden, K; Präger, TM; Radlanski, RJ; Rafayelyan, S | 1 |
Aslan, MK; Atasoy, P; Boybeyi, Ö; Gunal, YD; Kısa, U | 1 |
Chang, G; Li, Q; Lin, Y; Pang, T; Wang, C; Wang, J; Xu, H; Zhang, H | 1 |
Berkowitz, D; Coran, AG; Geyer, T; Mogilner, JG; Pollak, Y; Sukhotnik, I | 1 |
Amano, W; Kimoto, Y; Matsuo, A; Matsushita, M; Noji, S; Nozawa, K; Ogawa, Y; Oki, C; Shinozaki, Y; Shiozaki, M; Tanimoto, A | 1 |
Abbasi, MM; Hamishehkar, H; Jahanban-Esfahlan, R; Monfaredan, A | 1 |
Chai, AP; Mao, RR; Xu, L; Yang, YX; Yu, CL; Zhou, H | 1 |
Biswas, S; Nandakumar, K; Patel, A; Ramalingayya, GV; Shoja, MH | 1 |
Brito, GA; Cavalcanti, Pde F; de Araújo, AA; de Araújo, RF; de Medeiros, CA; de Moura Freire, MA; Freire, MA; Reinaldo, MP | 1 |
Abd Elhalem, SS; Darwish, AS; Shehata, IH; Wahba, SM | 1 |
Bako, F; Banfalvi, G; Kertai, P; Nagy, G; Trencsenyi, G | 1 |
Dabak, DO; Kocaman, N | 1 |
Alponti, RF; Mendes, MT; Silveira, PF; Yamasaki, SC | 1 |
Capitano, M; Hylander, BL; Kokolus, KM; Lee, CT; Leigh, ND; Repasky, EA | 1 |
Chen, Y; Dong, Y; Guan, Z; Niu, B; Niu, Y; Wang, J; Wang, X; Zhang, T | 1 |
Armagan, HH; Armagan, I; Bayram, D; Candan, IA; Celik, E; Uğuz, AC; Yigit, A | 1 |
Araújo, TE; Borba, PB; da Silva, AI; de Araújo Júnior, RF; de Araújo, AA; de Souza, FH; Nogueira, AC; Saldanha, TS | 1 |
Altenberger, S; Dao Trong, ML; Gottschalk, O; Jansson, V; Metz, P; Mutschler, W; Schmitt-Sody, M | 1 |
Bae, SC; Bae, YS; Choi, CB; Choi, JH; Jang, J; Kang, MS; Lee, HS; Park, JE; Seong, YR; Woo, YJ | 1 |
Ahmed, W; Nabil, T; Zaki, A | 1 |
Groen, AK; Havinga, R; Kuiken, NS; Rings, EH; Tissing, WJ | 1 |
Guo, GL; Schumacher, JD | 1 |
Chen, L; Liu, W; Shen, Z; Wang, C; Yan, J; Yang, H; Yang, J; Zhai, Z | 1 |
Ho Kim, J; Hun Park, S; Hyun Min, B; Ju Kim, B; Keun Han, D; Kim, DY; Kim, K; Reum Son, A; Suk Kim, M; Yong Jang, J; Yun Yin, X | 1 |
Boechat, AL; da Costa, AG; de Oliveira, CP; Guterres, SS; Malheiro, A; Pohlmann, AR; Tarragô, AM | 1 |
Bao, J; Chemaitilly, W; Frase, S; Green, DM; Janke, L; Lynch, J; Morgan, JA; Opferman, JT; Panetta, JC; Schuetz, JD; Wang, Y; Zheng, J | 1 |
Deleuran, B; Hauge, EM; Hetland, ML; Hvid, M; Hørslev-Petersen, K; Jalilian, B; Junker, P; Keller, KK; Kragstrup, TW; Laustsen, JK; Stengaard-Pedersen, K; Vorup-Jensen, T; Zhang, X; Østergaard, M | 1 |
Bonfá, E; Guido, MC; Maranhão, RC; Mello, SB; Tavares, ER | 1 |
Battastini, AM; Bergamin, LS; de Oliveira, CP; Figueiró, F; Guterres, SS; Jandrey, EH; Mendes, FB; Moritz, CE; Pettenuzzo, LF; Pohlmann, AR; Rockenbach, L; Sévigny, J | 1 |
Gao, HF; Li, LF; Liu, ZH; Shen, T; Shi, CJ; Wen, XS; Xian, CJ; Xu, XK | 1 |
Baykal, B; Elbey, B; Keskin, I; Kuş, S; Şahin, A; Yazgan, ÜC; Yılmaz, A | 1 |
Cavaco-Paulo, A; Gomes, A; Nogueira, E; Preto, A | 1 |
Altruda, F; Del Carmen Dominguez, M; Lorenzo, N; Silengo, L | 1 |
Al-Rjoub, MF; Augsburger, JJ; Banerjee, RK; Correa, ZM; Manna, S | 1 |
Armua-Fernandez, MT; Deplazes, P; Eichenberger, RM; Joekel, D; Matsumoto, J; Schweiger, A | 1 |
Merkley, CM; Tannock, IF; Winocur, G; Wojtowicz, JM | 1 |
Burcu, B; Kanter, M; Karabacak, R; Orhon, ZN; Yarali, O | 1 |
Garg, NK; Katare, OP; Sharma, G; Singh, B; Tyagi, RK | 1 |
Abd El-Twab, SM; Hozayen, WG; Hussein, OE; Mahmoud, AM | 1 |
Bauerová, K; Bezáková, L; Bilka, F; Čavojský, T; Harmatha, J; Hrádková, I; Kuncírová, V; Mihálová, D; Nosáľ, R; Pašková, Ľ; Paulíková, I; Poništ, S; Šišková, K | 1 |
Chen, S; Hou, J; Liu, Q; Wang, Y; Xing, J; Yu, B; Zhang, H; Zhang, R; Zhao, Q | 1 |
Chang, F; Chen, X; Ding, J; Feng, X; Gao, Z; Wang, Y; Yang, M; Zhuang, X | 1 |
Abulsamad, K; Adams, SL; Dobrzanski, MJ; Hylind, JC; Reome, JB; Rewers-Felkins, KA | 1 |
Jena, GB; Pawar, AA; Ramarao, P; Tripathi, DN; Vikram, A | 1 |
Draenert, FG; Draenert, K | 1 |
Ishih, A; Kino, H; Muregi, FW | 1 |
Bashenko, Y; Ben Lulu, S; Coran, AG; Mogilner, JG; Shamian, B; Shaoul, R; Shteinberg, D; Sukhotnik, I; Ure, BM | 1 |
Coran, AG; Karry, R; Lurie, M; Mogilner, JG; Shaoul, R; Shteinberg, D; Sukhotnik, I; Ure, BM | 1 |
Buwalda, B; Coppens, CM; Koolhaas, JM; Schagen, SB; Seigers, R; van Dam, FS; van der Most, PJ | 1 |
Garssen, J; Hartog, A; Hulsman, J | 1 |
Huysentruyt, LC; Seyfried, TN; Shelton, LM | 1 |
Kawai, J; Nagate, T; Nakayama, J | 1 |
Kesik, V; Kismet, E; Koseoglu, V; Kurt, B; Uysal, B | 1 |
Howarth, GS; Sundar, S; Tran, CD | 1 |
Butler, RN; Howarth, GS; Lymn, KA; Tooley, KL | 1 |
Bauerová, K; Jurcovicová, J; Rovenský, J; Stancíková, M; Svík, K; Utesený, J | 1 |
Ding, Y; Gao, Y; Li, A; Liu, J; Lv, X; Sun, H; Zhang, Z; Zhao, P | 1 |
Erwig, LP; Savage, CO | 1 |
Isik, A; Koca, SS; Ozercan, IH; Ozgen, M | 1 |
Cole, PD; Gulinello, M; Li, Y; Vijayanathan, V | 1 |
Hübner, C; Kern, P; Kocherscheidt, L; Pichler, BJ; Schmid, A; Soboslay, PT; Wehrl, H; Wiehr, S | 1 |
Goyal, AK; Kesarla, R; Murthy, RR; Nagle, A | 1 |
Kremer, J; Krishnaswami, S; Riese, RJ | 1 |
Chen, M; Kallenberg, CG | 1 |
Fukuwaka, S; Kobayashi, Y; Kohyama, N; Ohbayashi, M; Suzuki, M; Yamamoto, T; Yashiro, Y; Yasuda, M | 1 |
Augsburger, JJ; Banerjee, RK; Correa, ZM; Krishnamoorthy, M; Palakurthi, NK | 1 |
Kawane, K; Kitahara, Y; Nagata, S; Shimaoka, S; Tanaka, H | 1 |
Ambrozova, G; Bauerova, K; Ciz, M; Harmatha, J; Jancinova, V; Lojek, A; Mihalova, D; Nosal, R; Perecko, T | 1 |
Bauerova, K; Boldyrev, A; Drafi, F; Hrabarova, E; Juranek, I; Mihalova, D; Ponist, S; Soltes, L; Valachova, K | 1 |
Byun, YS; Chung, SK | 1 |
Cool, JC; Fan, CM; Foster, BK; Georgiou, KR; King, TJ; Scherer, MA; Xian, CJ | 1 |
Fan, C; Georgiou, KR; King, TJ; Xian, CJ | 1 |
Bole-Feysot, C; Boukhettala, N; Breuillé, D; Coëffier, M; Coquerel, Q; Déchelotte, P; Fetissov, SO; Sinno, MH; Terashi, M | 1 |
Baker, JR; Dunham, T; Majoros, IJ; Ward, BB | 1 |
Banji, D; Banji, OJ; Hayath, MS; Pinnapureddy, J; Saidulu, A | 1 |
Binns, MA; Tannock, I; Winocur, G | 1 |
Ali, N; Cole, PD; Gulinello, M; Vijayanathan, V | 1 |
Asl, NA; Asvadi, A; Asvadi, I; Hajipour, B; Khodadadi, A; Roshangar, L | 1 |
Aguilar, D; Alpizar-Rodríguez, D; Cruz-Robles, D; Escobar-Hernández, S; Férez-Blando, K; Furuzawa-Carballeda, J; Galindo-Feria, AS; Llorente, L; Macip-Rodríguez, P; Soto-Abraham, V | 1 |
Bulut, H; Calişkan, M; Kilinç, K; Sanli, AM; Sargon, MF; Sekerci, Z; Serbes, G | 1 |
Cavalcanti, SC; Corrêa, L; Luz, JG | 1 |
Binns, MA; Henkelman, M; Tannock, IF; Winocur, G; Wojtowicz, JM; Zhang, H | 1 |
Hashizume, M; Matsumoto, I; Mihara, M; Sumida, T; Suzuki, M; Tanaka, K; Yoshida, H | 1 |
Acin, F; Bleda, S; De Haro, J; Esparza, L | 1 |
Baharav, E; Bar, M; Gil-Ad, I; Karp, L; Taler, M; Weinberger, A; Weizman, A | 1 |
Baek, SH; Hong, KW; Kim, CD; Kim, HY; Lee, CW; Lee, SW; Park, SY | 1 |
Beyer, C; Dees, C; Distler, A; Distler, JH; Distler, O; Gelse, K; Khodzhigorova, A; Lang, V; Schett, G; Schneider, H | 1 |
Bhatia, M; Garg, LN; Gupta, S; Kumar, S | 1 |
Chuan-Ying, Y; Lei, Z | 1 |
Ahmad, B; Hashmi, FK; Hussain, K; Islam, M; Muhammad, K; Saleem, U; Tipu, MK | 1 |
Bejar, D; Coran, AG; Mogilner, JG; Nativ, O; Roitburt, A; Sukhotnik, I | 1 |
Ichagichu, M; Karanja, SM; Kariuki, T; Kokwaro, G; Ngotho, M; Nzila, A; Ozwara, H | 1 |
Borea, PA; Corciulo, C; Gessi, S; Giacuzzo, S; Govoni, M; Merighi, S; Padovan, M; Targa, M; Varani, K; Vincenzi, F | 1 |
Dalmarco, EM; Fröde, TS; Medeiros, YS | 1 |
Achira, M; Kume, T; Totsuka, R | 1 |
Balow, JE; Langford, CA | 1 |
Alladi, A; Gupta, DK; Gupta, SD | 1 |
Istok, R; Rovensky, J; Stancíková, M; Svík, K | 1 |
Kimura, H; Kita, E; Konishi, M; Mikasa, K; Narita, N; Takahashi, K; Yoshimoto, E | 1 |
Goto, T; Magari, K; Miyata, S; Mutoh, S; Nishigaki, F; Ohkubo, Y | 1 |
Gause, A; Schnabel, A | 1 |
Choi, S; Haber, M; Liem, NL; Lock, RB; MacKenzie, KL; Milross, CG; Norris, MD; Papa, RA; Ramirez, CD; Rice, AM; Schmid, MA; Tajbakhsh, M | 1 |
Araujo, DH; Brito, GA; Carneiro-Filho, BA; Carvalho, GH; Cavalcante, MC; Lima, AA; Lima, IP; Lima, V; Monteiro, SM; Ribeiro, RA; Santos, FN | 1 |
Akabane, H; Komai, M; Masuda, T; Nagai, H; Nagao, K; Tanaka, H | 1 |
Artym, J; Zimecki, M | 1 |
M'Rabet, L; van Beek, NM; van den Berg, JJ; van't Land, B | 1 |
Fiehn, C; Freudenberg-Konrad, S; Funk, J; Gay, S; Ho, AD; Krienke, S; Müller-Ladner, U; Sinn, H; Wunder, A | 1 |
Boehmer, LN; John, J; Siegel, JM; Wu, MF | 1 |
Mahmood, U; Müller-Ladner, U; Tung, CH; Weissleder, R; Wunder, A | 1 |
Bajtner, E; Holmdahl, R; Lange, F; Nandakumar, KS; Rintisch, C; Sack, U | 1 |
Bush, K; Life, P; Morgan, R; Patten, C; Rioja, I; Trill, J; Wooley, P | 1 |
Butler, RN; Davidson, GP; Howarth, GS; Pelton, NS; Tivey, DR | 1 |
Kakinuma, C; Kuwayama, C; Naba, H; Ogihara, T; Ohnishi, S | 1 |
Chen, LJ; Cheng, XY; Han, YQ; Sun, XJ; Zhao, GF | 1 |
Baker, JR; Balogh, LP; Candido, KA; Cao, Z; Khan, MK; Kukowska-Latallo, JF; Majoros, IJ; Nigavekar, SS; Thomas, TP | 1 |
Balthasar, JP; Lobo, ED | 1 |
Cronstein, BN; D'Eustachio, P; Delano, DL; Desai, A; Fernandez, P; Montesinos, MC; Wilder, T; Wiltshire, T | 1 |
Moreland, LW; Teng, GG; Turkiewicz, AM | 1 |
Blatnik, AF; Brausi, M; Hickey, DP; Soloway, MS | 1 |
Avci, A; Cetin, R; Devrim, E; Durak, I; Ergüder, BI; Kiliçoğlu, B | 1 |
Cuzzocrea, S; Di Paola, R; Mirshafiey, A; Saadat, F | 1 |
Gardner, J; Gonen, M; Heaney, M; O'Connor, OA; Sirotnak, F; Smith, EA; Teruya-Feldstein, J; Toner, LE; Vrhovac, R | 1 |
Hioki, Y; Kusuzaki, K; Matsumine, A; Seto, M; Sonoda, J; Tomoda, R; Uchida, A | 1 |
Deng, SX; Edward, DP; Fiscella, R; Goldstein, DA; Gupta, S; Penland, S; Tessler, HH | 1 |
Angelov, L; Diglaw, T; Fazio, V; Franic, L; Granata, T; Hallene, K; Hernandez, N; Janigro, D; Marchi, N; Masaryk, T; Najm, I | 1 |
D'Argenio, G; Di Marzo, V; Gianfrani, C; Grandone, I; Mazzarella, G; Nigam, S; Petrosino, S; Scaglione, G; Sorrentini, I; Valenti, M | 1 |
Akabas, MH; Cabelof, DC; Goldman, ID; Jansen, M; Malhotra, U; Matherly, LH; Min, SH; Qiu, A; Tsai, E; Zhao, R | 1 |
Guchelaar, HJ; Huizinga, TW; Wessels, JA | 1 |
Garman, R; Housman, M; Joseph, A; Munroe, K; Richards, S | 1 |
Jansson, L; Karlsson, A; Karlsson, L; Melgar, S; Michaëlsson, E; Rehnström, E; Utkovic, H | 1 |
Chung, H; Hong, I; Kang, KS; Kim, HL; Kim, JH; Kim, M; Kong, G; Lee, BH; Lee, MH; Lee, MO; Yoon, BI | 1 |
Ryan, SJ; Sorgente, N; Sunalp, M; Wiedemann, P | 1 |
Lo, GS; Longenecker, JB | 1 |
Blatnik, A; Matheny, RB; Niell, HB; Soloway, MS | 1 |
Drago, JR; Palmer, J | 1 |
Ariyan, S; Goldberg, NH; Kraft, RL | 1 |
Chang, BK; Gutman, R | 1 |
Lamm, DL; Livingston, RB; Stogdill, BJ | 1 |
Bottiglieri, T; Hyland, K; Reynolds, EH | 1 |
Devineni, D; Gallo, JM; Klein-Szanto, A | 1 |
Adachi, M; Gonokami, Y; Kobayashi, H; Konno, S | 1 |
Howes, A; Kernan, WJ; Mullenix, PJ; Sallan, SE; Schunior, A; Tarbell, NJ; Waber, DP | 1 |
Faenza, S; Fini, M; Giardino, R; Giavaresi, G; Martini, L; Morrone, G; Spighi, M | 1 |
Camilleri, JP; Williams, AS; Williams, BD | 1 |
Cronstein, BN; Naime, D; Ostad, E | 1 |
Gaetje, R; Lierse, W; Popp, LW; Status, S | 1 |
Das, PK; Sarkar, HS; Sett, R | 1 |
Breimer, DD; Danhof, M; de Boer, AG; de Lange, EC; de Vries, JD; Zurcher, C | 1 |
Dunkley, PR; Francis, JL; Noltorp, RS; O'Loughlin, EV; Warden, RA | 1 |
Dayan, M; Mozes, E; Segal, R | 1 |
Mihara, M; Moriya, Y; Takagi, N; Takeda, Y; Urakawa, K | 1 |
Neidel, J; Schroers, B; Sintermann, F | 1 |
Aronson, J; Jarka, DE; Nicholas, RW | 1 |
Dayan, M; Mozes, E; Nezlin, R; Zinger, H | 1 |
Fukui, H; Yamamoto, M | 1 |
Amos, N; Goodfellow, RM; Jones, SG; Williams, AS; Williams, BD | 1 |
Joussen, AM; Kirchhof, B; Kruse, FE; Völcker, HE | 1 |
Domb, AJ; Shikani, AH | 1 |
DeLeo, JA; Hashizume, H; Rutkowski, MD; Weinstein, JN | 1 |
Burger, D; Dayer, JM; Edwards , CK; Feige, U | 1 |
Bittner, C; Feyerabend, T; Peters, SO; Raap, M; Remmert, S; Robins, IH; Sieg, P; Sommer, K; Wiedemann, GJ | 1 |
Fujimura, A; Kasahara, K; Kobayashi, E; Nagai, H; Sugimoto, K; To, H; Uchida, H; Xiu, D | 1 |
Alarcón, GS; Arani, R; Baggott, JE; Bernreuter, WK; Gay, RE; Morgan, SL | 1 |
Akamatsu, K; Kawamura, A; Mihara, M; Takagi, N; Takeda, Y; Urakawa, K | 1 |
Frerichs, J; Hoijer, M; Jager, D; Koetsier, M; M'Rabet, L; Meijer, HP; Smeets, RL; van't Land, B | 1 |
Chan, ES; Cronstein, BN | 1 |
Bocaccino, CA; Greenberger, JS; Moloney, WC; Szot, SJ | 1 |
Walker, MD; Weiss, HD | 1 |
Thierfelder, S | 1 |
Dorick, DM; Moccio, DM; Sirotnak, FM | 1 |
Conge, G | 1 |
Dicke, KA; Hendriks, W; Peters, L; Spitzer, G; Stevens, EE | 1 |
Siddall, RA | 1 |
Hasegawa, H; Posner, JB; Shapiro, WR | 1 |
Chemik, NL; Posner, JB; Shapiro, WR; Ushio, Y; Young, DF | 1 |
Bartocci, A; Bonmassar, E; Frati, L; Riccardi, C | 1 |
Forbes, RD; Guttmann, RD; Klassen, J; Knaack, J; Kuramochi, T | 1 |
McCullough, JL; Weinstein, GD | 1 |
Madden, JW | 1 |
Bergsagel, DE; Librach, SL; Ogawa, M | 1 |
Kaufmann, M; Mattern, J; Volm, M; Wayss, K | 1 |
Ezeamuzie, IC; Njoku, AC | 1 |
Broadwater, JR; Jensen, JC; Klimberg, VS; Lang, NP; Nwokedi, E; Pappas, AA; Westbrook, KC | 1 |
Baggott, JE; Freeberg, LE; Gay, RE; Gay, S; Gopal Nair, M; Hudson, BB; Koopman, WJ; Krumdieck, CL; Morgan, SL; Vaughn, WH | 1 |
Barr-Nea, L; Sandovsky-Losica, H; Segal, E | 1 |
Bethouart, M; Buchet-Bouverne, B; Crépin, G; Lecuru, F; Querleu, D; Vasquez, G | 1 |
Bale, G; Chesney, TM; Noah, PW; Rosenberg, EW; Skinner, RB; Xu, B | 1 |
Belitsky, P; Blair, AH; Ghose, T; Kralovec, J; Singh, M | 1 |
Fleischhauer, D; Gassmann, W; Loeffler, H; Mueller-Ruchholtz, W; Uharek, L; Wottge, HU | 1 |
Ladiges, WC; Storb, R; Thomas, ED | 1 |
Mitchell, IC; Turk, JL | 1 |
Niell, HB; Soloway, MS; Wood, CA | 1 |
Kerwar, SS; Oronsky, AL | 1 |
Okeda, R; Shibutani, M | 1 |
D'Angio, G; Davidson, TL; Levine, JD; Micalizzi, M; Packer, RJ; Yanovski, JA | 1 |
Abernathey, CD; Kooistra, KL; Laws, ER; Wilcox, GL | 1 |
Deeg, HJ; Luk, K; Shulman, HM; Shuman, WB; Storb, R | 1 |
Galivan, J; Kerwar, SS; Oronsky, AL; Rath, N; Ridge, SC; Zabriske, J | 1 |
Beidler, DE; Dillman, RO; Johnson, DE; Koziol, JA; Myers, LJ; Shawler, DL; Sweet, MD; Tudor, SD | 1 |
Ben-Nun, A; Cohen, IR; Przuntek, H; Vohl, ML; Wekerle, H; Westarp, ME | 1 |
Chick, BF; Grace, J; Harker, GJ; Stephens, FO; Wass, J; Zbroja, RA | 1 |
Bretscher, P; O'Callaghan, JW; Russell, AS | 1 |
Drago, JR; Lombard, J | 1 |
Anderson, C | 1 |
Glynn, JP; Goldberg, AI; Goldin, A; Kende, M; Mantel, N | 1 |
Husberg, BS | 1 |
Sindram, PJ; Snow, GB | 1 |
Carnegie, PR; Coates, AS; Mackay, IR | 1 |
Kline, I | 1 |
Ericson, U; Lockner, D | 1 |
Berenbaum, MC; Bundick, RV; Reittie, JR; Sheard, CE | 1 |
Shapiro, WR | 2 |
Hoshino, T; Wilson, CB | 1 |
Hreshchyshyn, MM; Kawai, N | 1 |
Husk, M; Mount, BM; Thelmo, WL | 1 |
Husk, M; Mount, BM | 1 |
Cheeks, JB; Laster, WR; Schabel, FM; Skipper, HE; Trader, MW | 1 |
Amiel, JL; De Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Pouillart, P; Rappaport, H; Rosenfeld, C; Schneider, M; Schwarzenberg, L; Weiner, R | 1 |
Bleyer, WA; Yancey, ST | 1 |
Boesen, EA | 1 |
Hansen, HH | 1 |
Ivankovic, S; Zeller, WJ | 1 |
Frei, E; Goldin, A; Henderson, ES; Holland, JF; Newman, JW; Sandberg, JS | 1 |
DiMartino, MJ; Misher, A; Walz, DT | 1 |
Ritterson, AL | 1 |
Zubrod, CG | 1 |
Holland, JF | 1 |
De Vita, VT; Kies, MW; Lisak, RP; Vogel, CL | 1 |
Mount, BM; Stevens, LC; Whitmore, WF | 1 |
Ausman, JI; Rall, DP; Shapiro, WR | 1 |
Brockman, RW; Lloyd, HH; Mellett, LB; Montgomery, JA; Schabel, FM; Skipper, HE; Wilkoff, LJ | 1 |
Aoki, T; Hreshchyshyn, MM; Koide, Y | 1 |
Edwards, AJ; Hurd, CM; Rowland, GF; Sumner, MR | 1 |
27 review(s) available for methotrexate and Disease Models, Animal
Article | Year |
---|---|
Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics.
Topics: Amiodarone; Animals; Bleomycin; Disease Models, Animal; Idiopathic Pulmonary Fibrosis; Lung; Lung Diseases, Interstitial; Methotrexate | 2022 |
Dose Issues in Cancer Chemotherapy.
Topics: Adolescent; Adult; Animals; Antimetabolites, Antineoplastic; Child; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Neoplasms | 2020 |
Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Chemokine CCL2; Chemokine CCL4; Chemokine CCL5; Chemokines; Cytokines; Diphosphonates; Disease Models, Animal; Humans; Immunosuppressive Agents; Inflammasomes; Interleukin-12; Interleukin-6; Methotrexate; Mice; Mitogen-Activated Protein Kinases; Monocytes; Osteomyelitis; Receptors, Interleukin-2; Signal Transduction; Sulfasalazine; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2017 |
A comprehensive review on adult onset Still's disease.
Topics: Adaptive Immunity; Adrenal Cortex Hormones; Age of Onset; Animals; Arthritis; Biomarkers; Blood Sedimentation; C-Reactive Protein; Disease Models, Animal; Ferritins; Humans; Immunity, Innate; Macrophage Activation Syndrome; Methotrexate; Still's Disease, Adult-Onset; Survival Analysis; Young Adult | 2018 |
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; CD40 Antigens; CD40 Ligand; Diabetes Mellitus, Type 2; Disease Models, Animal; Hematopoiesis; Humans; Inflammasomes; Interleukin-18; Interleukin-1beta; Interleukin-6; Methotrexate; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Signal Transduction; Stroke; Thrombosis; Triggering Receptor Expressed on Myeloid Cells-1 | 2019 |
Mechanistic review of drug-induced steatohepatitis.
Topics: Amiodarone; Animals; Camptothecin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fatty Liver; Hepatocytes; Humans; Irinotecan; Lipid Metabolism; Liver; Methotrexate; Mitochondria, Liver; Organoplatinum Compounds; Oxaliplatin; Perhexiline; Tamoxifen; Tetracycline; Valproic Acid | 2015 |
Update on Therapeutic Approaches for Rheumatoid Arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; B-Lymphocytes; Disease Models, Animal; Humans; Methotrexate; Pain Management; Synovial Membrane; T-Lymphocytes | 2016 |
ANCA-associated vasculitides: advances in pathophysiology and treatment.
Topics: Animals; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Disease Models, Animal; Disease Progression; Humans; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid | 2010 |
Inhibition of JAK kinases in patients with rheumatoid arthritis: scientific rationale and clinical outcomes.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Health Status; Humans; Janus Kinase 3; Methotrexate; Piperidines; Pyrimidines; Pyrroles; Severity of Illness Index; Treatment Outcome | 2010 |
ANCA-associated vasculitides--advances in pathogenesis and treatment.
Topics: Animals; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Disease Models, Animal; Glucocorticoids; Humans; Methotrexate; Mice; Remission Induction; Rituximab | 2010 |
Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children.
Topics: Animals; Antineoplastic Agents; Bone Development; Bone Diseases; Child; Disease Models, Animal; Humans; Methotrexate; Neoplasms; Rats | 2011 |
New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Disease Models, Animal; Humans; Kidney; Kidney Diseases; Methotrexate; Mice; Mycophenolic Acid; Rituximab; Vasculitis | 2003 |
[Rheumatology 2003-part I: research news concerning pathogenesis, epidemiology, diagnosis, and therapy of chronic inflammatory joint diseases].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cells, Cultured; Clinical Trials as Topic; Diagnosis, Differential; Disease Models, Animal; Female; HLA Antigens; Humans; Infliximab; Methotrexate; Middle Aged; Placebos; Polymorphism, Genetic; Pregnancy; Prognosis; Quality of Life; Randomized Controlled Trials as Topic; Rats; Spondylarthropathies; Spondylitis, Ankylosing; Time Factors | 2003 |
[Effect of methotrexate on the immune response in selected experimental models].
Topics: Animals; Antibody Formation; Apoptosis; Autoimmune Diseases; Cell Cycle; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Folic Acid Antagonists; Hematopoiesis; Humans; Immunity, Cellular; Immunosuppressive Agents; Methotrexate | 2004 |
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis.
Topics: Adenosine; Animals; Apoptosis; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Clinical Trials as Topic; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Folic Acid; Humans; Immunity, Cellular; Immunosuppression Therapy; Male; Methotrexate; Reactive Oxygen Species; Sensitivity and Specificity; Treatment Outcome | 2008 |
The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.
Topics: AIDS Dementia Complex; Animals; Brain Diseases; Dementia; Disease Models, Animal; Epilepsy; Humans; Metabolism, Inborn Errors; Methotrexate; Methylation; Multiple Sclerosis; Neurotransmitter Agents; Parkinson Disease; Receptors, Neurotransmitter; S-Adenosylmethionine; Spinal Cord Diseases | 1994 |
Anti-interleukin-1 therapy in rheumatic diseases.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Disease Models, Animal; Drug Therapy, Combination; Genetic Therapy; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Methotrexate; Sialoglycoproteins; Treatment Outcome | 2001 |
Molecular action of methotrexate in inflammatory diseases.
Topics: Adenosine; Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Methotrexate; Receptors, Purinergic P1 | 2002 |
Chemotherapy in the treatment of malignant brain tumors.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Cyclophosphamide; Disease Models, Animal; Drug Evaluation; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Nitrogen Mustard Compounds; Nitrosourea Compounds; Plicamycin; Podophyllotoxin; Procarbazine; Vincristine | 1975 |
Experimental bone marrow transplantation.
Topics: Anemia, Aplastic; Animals; Antilymphocyte Serum; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Chick Embryo; Cyclophosphamide; Disease Models, Animal; Dogs; Graft vs Host Reaction; Haplorhini; Histocompatibility Antigens; Humans; Immunization, Passive; Methotrexate; Mice; Mice, Inbred Strains; Rabbits; Radiation Injuries, Experimental; Rats; T-Lymphocytes; Tissue Donors; Transfusion Reaction; Transplantation, Homologous | 1975 |
Cytokinetics and chemotherapy of psoriasis.
Topics: Administration, Topical; Animals; Disease Models, Animal; Drug Administration Schedule; Humans; Kinetics; Methotrexate; Mice; Mice, Nude; Psoriasis; Skin Absorption | 1976 |
Plastic surgery and burns.
Topics: Animals; Bone Regeneration; Burns; Cicatrix; Collagen; Disease Models, Animal; Drug Interactions; Guinea Pigs; Humans; Leukocytes; Methotrexate; Rabbits; Rats; Salicylates; Skin Transplantation; Surgery, Plastic; Tendon Injuries; Wound Healing | 1976 |
Canine models of bone marrow transplantation.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow Transplantation; Cyclosporins; Disease Models, Animal; Dogs; Graft Enhancement, Immunologic; Graft vs Host Disease; Immunosuppression Therapy; Methotrexate; Models, Biological | 1990 |
The effect of selected immunomodulating agents on experimental contact reactions.
Topics: Animals; Azathioprine; Basophils; Cell Division; Croton Oil; Cyclophosphamide; Cyclosporins; Dermatitis, Contact; Disease Models, Animal; Drug Administration Schedule; Female; Guinea Pigs; Hypersensitivity, Delayed; Immunity, Cellular; Immunosuppression Therapy; Mast Cells; Methotrexate; Oxazolone | 1985 |
Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.
Topics: Animals; Antibody Formation; Antigens; Autoimmune Diseases; Cell Migration Inhibition; Cyclophosphamide; Disease Models, Animal; Encephalomyelitis; Guinea Pigs; Haplorhini; Humans; Immunity, Cellular; Immunization; Immunoglobulin G; Lymphocyte Activation; Methotrexate; Multiple Sclerosis; Myelin Basic Protein; Nerve Tissue Proteins; Protein Binding; Rabbits; Rats; Skin Tests; Virus Diseases | 1973 |
Chemotherapy of bronchial carcinoma.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Blood Cell Count; Bone Marrow Diseases; Bronchial Neoplasms; Cyclophosphamide; Disease Models, Animal; Drug Combinations; Fluorouracil; Humans; Methotrexate; Pleural Effusion; Prognosis; Vascular Diseases; Vena Cava, Superior; Vincristine | 1973 |
The chemotherapy of human and animal acute leukemia.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cell Division; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Humans; Kinetics; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Neoplasms; Prednisone; Remission, Spontaneous; RNA, Neoplasm; Vincristine | 1971 |
2 trial(s) available for methotrexate and Disease Models, Animal
Article | Year |
---|---|
Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response.
Topics: Adalimumab; Adult; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; CD18 Antigens; Chronic Disease; Disease Models, Animal; Female; Humans; Leukocytes, Mononuclear; Male; Methotrexate; Mice, Inbred C57BL; Mice, Inbred Strains; Middle Aged; Synovial Fluid; Treatment Outcome | 2016 |
The chemotherapy of human and animal acute leukemia.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cell Division; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Humans; Kinetics; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Neoplasms; Prednisone; Remission, Spontaneous; RNA, Neoplasm; Vincristine | 1971 |
330 other study(ies) available for methotrexate and Disease Models, Animal
Article | Year |
---|---|
Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Division; Disease Models, Animal; Female; Folic Acid Antagonists; Glutamic Acid; In Vitro Techniques; Inflammatory Bowel Diseases; Liver; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Quinazolines; Rats; Spleen; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2003 |
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Capillaries; Disease Models, Animal; Estrone; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Osteosclerosis; Penicillin G; RNA, Messenger | 2004 |
Fused tricyclic indoles as S1P₁ agonists with robust efficacy in animal models of autoimmune disease.
Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Female; Humans; Immunologic Factors; Indoles; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Microsomes; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Structure-Activity Relationship | 2012 |
N2-Trimethylacetyl substituted and unsubstituted-N4-phenylsubstituted-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines: design, cellular receptor tyrosine kinase inhibitory activities and in vivo evaluation as antiangiogenic, antimetastati
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Design; Humans; Melanoma, Experimental; Mice; Mice, Nude; Microwaves; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship | 2013 |
Synthesis, antinociceptive and anti-inflammatory effects of porphyrins.
Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Disease Models, Animal; Edema; Erythrocytes; Hemolysis; Indomethacin; Male; Mice; Naproxen; Nociception; Pain; Pain Measurement; Porphyrins; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate | 2015 |
Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitors.
Topics: Amines; Animals; Arthritis; Binding Sites; Disease Models, Animal; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Mice; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Binding; Protein Isoforms; Protein Kinase Inhibitors; Protein Structure, Tertiary; Structure-Activity Relationship; Triazines | 2016 |
Effects of Koumine on Adjuvant- and Collagen-Induced Arthritis in Rats.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Collagen; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Female; Gelsemium; Indole Alkaloids; Interleukin-1beta; Male; Methotrexate; Molecular Structure; Rats; Rats, Inbred Lew; Rats, Wistar; Tumor Necrosis Factor-alpha | 2016 |
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer.
Topics: Animals; Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Disease Models, Animal; Histone Deacetylase Inhibitors; Humans; Hydrocarbons, Fluorinated; Hydroxamic Acids; Mice; Pancreatic Neoplasms; Sulfonamides | 2019 |
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Auxiliary in vitro and in vivo biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis.
Topics: Aminopterin; Animals; Antirheumatic Agents; Apoptosis; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Hydrogen Peroxide; Injections, Intraperitoneal; Methotrexate; Molecular Structure; Prodrugs; Rats; Reactive Oxygen Species; Structure-Activity Relationship | 2020 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Methotrexate Ameliorates Systemic Inflammation and Septic Associated-Lung Damage in a Cecal Ligation and Puncture Septic Rat Model.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cecum; Disease Models, Animal; Inflammation; Ligation; Lung; Male; Methotrexate; Punctures; Rats; Rats, Sprague-Dawley; Sepsis | 2021 |
Nephroprotective effect of naringin in methotrexate induced renal toxicity in male rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Caspase 3; Disease Models, Animal; Flavanones; Inflammation Mediators; Interleukin-6; Kidney; Kidney Diseases; Male; Methotrexate; Oxidative Stress; Rats; Tumor Necrosis Factor-alpha | 2021 |
Ginkgo biloba extract (EGb 761) mitigates methotrexate-induced testicular insult in rats: Targeting oxidative stress, energy deficit and spermatogenesis.
Topics: Animals; Antioxidants; Disease Models, Animal; Energy Metabolism; Fibrosis; Ginkgo biloba; Male; Methotrexate; NF-E2-Related Factor 2; Oxidative Stress; Plant Extracts; Rats, Wistar; Spermatogenesis; Spermatozoa; Testicular Diseases; Testis | 2021 |
Effect of metformin treatment on memory and hippocampal neurogenesis decline correlated with oxidative stress induced by methotrexate in rats.
Topics: Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Doublecortin Protein; Hippocampus; Male; Memory; Memory Disorders; Metformin; Methotrexate; Neurogenesis; NF-E2-Related Factor 2; Nootropic Agents; Open Field Test; Oxidative Stress; Prefrontal Cortex; Rats, Sprague-Dawley | 2021 |
Efficacy of Boron Neutron Capture Therapy in Primary Central Nervous System Lymphoma: In Vitro and In Vivo Evaluation.
Topics: Animals; Apoptosis; Boron; Boron Neutron Capture Therapy; Brain; Cell Line, Tumor; Cell Survival; Central Nervous System Neoplasms; Cranial Irradiation; Disease Models, Animal; Humans; Lymphoma; Methotrexate; Mice; Phenylalanine; Tissue Distribution | 2021 |
Targeting inflammation, autophagy, and apoptosis by troxerutin attenuates methotrexate-induced renal injury in rats.
Topics: Acute Kidney Injury; Animals; Apoptosis; Autophagy; Disease Models, Animal; Humans; Hydroxyethylrutoside; Inflammation; Male; Methotrexate; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Vasoconstrictor Agents | 2022 |
Cognitive impairment persists at least 1 year after juvenile rats are treated with methotrexate.
Topics: Age Factors; Animals; Antimetabolites, Antineoplastic; Apoptosis; Behavior, Animal; Cancer Survivors; Cognitive Dysfunction; Disease Models, Animal; Female; Male; Methotrexate; Microglia; Neurogenesis; Neurotoxicity Syndromes; Rats; Rats, Long-Evans; Sex Factors; Time Factors | 2022 |
Capsaicin ameliorate the nephrotoxicity induced by methotrexate.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Capsaicin; Disease Models, Animal; Inflammation Mediators; Kidney; Kidney Diseases; Male; Methotrexate; Oxidative Stress; Rats, Sprague-Dawley | 2021 |
Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carbon-Sulfur Lyases; Disease Models, Animal; Drug Resistance, Neoplasm; Humans; Methotrexate; Mice; Mice, Nude; Osteosarcoma; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2022 |
Bioavailability, anti-inflammatory and anti-arthritic effect of Acetyl Keto Boswellic acid and its combination with methotrexate in an arthritic animal model.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Bilirubin; Biological Availability; Boswellia; Diclofenac; Disease Models, Animal; Malondialdehyde; Methotrexate; Plant Extracts; Triterpenes | 2022 |
Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis.
Topics: Animals; Ceramides; Cholesterol; Disease Models, Animal; Imiquimod; Methotrexate; Mice; Mice, Inbred BALB C; Psoriasis; Skin; Surface-Active Agents | 2022 |
Prenatal methotrexate injection increases behaviors possibly associated with depression and/or autism in rat offspring; A new animal model for mental disorder, based on folate metabolism deficit during pregnancy.
Topics: Animals; Autistic Disorder; Behavior, Animal; Depression; Disease Models, Animal; DNA; Female; Folic Acid; Humans; Mental Disorders; Methotrexate; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Vitamins | 2022 |
Chemo-photothermal therapeutic effect of chitosan-gelatin hydrogels containing methotrexate and melanin on a collagen-induced arthritis mouse model.
Topics: Animals; Arthritis, Experimental; Chitosan; Disease Models, Animal; Doxorubicin; Gelatin; Hydrogels; Infrared Rays; Melanins; Methotrexate; Mice; Phototherapy | 2022 |
Vaccines prevent reinduction of rheumatoid arthritis symptoms in collagen-induced arthritis mouse model.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Inflammation; Methotrexate; Mice; Vaccines | 2023 |
Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
Topics: Animals; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin; Cisplatin; Disease Models, Animal; Female; Heterografts; Humans; Methotrexate; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2023 |
Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model.
Topics: Administration, Cutaneous; Animals; Disease Models, Animal; Female; Folic Acid Antagonists; Imiquimod; Immunosuppressive Agents; Liposomes; Methotrexate; Mice, Inbred BALB C; Psoriasis | 2019 |
Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis.
Topics: Acrylates; Administration, Cutaneous; Animals; Antipsychotic Agents; Disease Models, Animal; Drug Compounding; Drug Liberation; Gels; Guinea Pigs; Humans; Lecithins; Liposomes; Methotrexate; Mice; Parakeratosis; Permeability; Psoriasis; Salicylic Acid; Skin; Skin Absorption | 2019 |
Effect of lutein on methotrexate-induced oxidative lung damage in rats: a biochemical and histopathological assessment.
Topics: Animals; Antioxidants; Disease Models, Animal; Glutathione; Interleukin-1beta; Lung; Lung Diseases; Lutein; Male; Malondialdehyde; Methotrexate; Oxidative Stress; Peroxidase; Rats, Wistar; Tumor Necrosis Factor-alpha | 2019 |
Melatonin rescued methotrexate-induced spatial deficit and hyperhomocysteinemia and increased asymmetric dimethylarginine in plasma and dorsal hippocampus in developing rats.
Topics: Animals; Animals, Newborn; Antimetabolites, Antineoplastic; Arginine; Disease Models, Animal; Hippocampus; Hyperhomocysteinemia; Male; Maze Learning; Melatonin; Methotrexate; Rats; Rats, Sprague-Dawley; Spatial Behavior | 2020 |
Hyaluronic Acid-Based Dissolving Microneedle Patch Loaded with Methotrexate for Improved Treatment of Psoriasis.
Topics: Animals; Disease Models, Animal; Drug Delivery Systems; Female; Humans; Hyaluronic Acid; Methotrexate; Mice; Mice, Inbred BALB C; Needles; Psoriasis | 2019 |
Early Effects of Cyclophosphamide, Methotrexate, and 5-Fluorouracil on Neuronal Morphology and Hippocampal-Dependent Behavior in a Murine Model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; CA1 Region, Hippocampal; Chemotherapy, Adjuvant; Cyclophosphamide; Dendrites; Dendritic Spines; Disease Models, Animal; Female; Fluorouracil; Hippocampus; Methotrexate; Mice; Neurons; Quality of Life | 2020 |
Nanoparticle-Coupled Topical Methotrexate Can Normalize Immune Responses and Induce Tissue Remodeling in Psoriasis.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Female; Gold; Humans; Imiquimod; Immunity; Methotrexate; Mice; Mice, Inbred C57BL; Nanoparticles; Psoriasis; Skin; Th17 Cells; Xenograft Model Antitumor Assays | 2020 |
Preparation and Characterization of Fe
Topics: 3T3 Cells; Animals; Apoptosis; Cell Line, Tumor; Central Nervous System Neoplasms; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Female; Ferric Compounds; Humans; Hyperthermia, Induced; Lymphoma; Magnetite Nanoparticles; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Temperature; Toxicity Tests, Acute | 2019 |
Modulation of methotrexate-induced intestinal mucosal injury by dietary factors.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Feces; Gastrointestinal Microbiome; Intestinal Diseases; Intestinal Mucosa; Male; Metabolome; Methotrexate; Mice, Inbred C57BL; Sucrose; Survival Analysis; Tissue Distribution | 2020 |
Andrographolide ameliorates oxidative stress, inflammation and histological outcome in complete Freund's adjuvant-induced arthritis.
Topics: Animals; Antioxidants; Arthritis, Experimental; Arthritis, Rheumatoid; Catalase; Disease Models, Animal; Diterpenes; Edema; Freund's Adjuvant; Glutathione; Inflammation; Interleukin-1beta; Interleukin-6; Joints; Male; Methotrexate; Neutrophils; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Synovial Membrane; Tumor Necrosis Factor-alpha | 2020 |
Protective effects of hesperidin against MTX-induced hepatotoxicity in male albino rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation; Heme Oxygenase (Decyclizing); Hesperidin; Inflammation Mediators; Liver; Male; Methotrexate; NF-E2-Related Factor 2; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction; Tumor Suppressor Protein p53 | 2020 |
Long-term clinically relevant rodent model of methotrexate-induced cognitive impairment.
Topics: Animals; Antimetabolites, Antineoplastic; Cognitive Dysfunction; Diffusion Tensor Imaging; Disease Models, Animal; Female; Male; Methotrexate; Random Allocation; Rats; Rats, Sprague-Dawley; White Matter | 2020 |
Drug interaction study of flavonoids toward OATP1B1 and their 3D structure activity relationship analysis for predicting hepatoprotective effects.
Topics: Animals; Bosentan; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Flavonoids; Food-Drug Interactions; HEK293 Cells; Herb-Drug Interactions; Humans; Liver; Liver-Specific Organic Anion Transporter 1; Male; Methotrexate; Molecular Conformation; Organic Anion Transporters; Rats, Sprague-Dawley; Structure-Activity Relationship | 2020 |
Application of either nano fibrillated cellulose methotrexate or nano silicon dioxide methotrexate composites against renal fibrosis in leukemia rat model.
Topics: Animals; Antimetabolites, Antineoplastic; Biomarkers; Cellulose; Disease Models, Animal; Drug Carriers; Fibrosis; Kidney Diseases; Leukemia; Male; Methotrexate; Nanofibers; Nanoparticles; Rats; Silicon Dioxide | 2020 |
Naringin alleviates methotrexate-induced liver injury in male albino rats and enhances its antitumor efficacy in HepG2 cells.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Biomarkers; Carcinoma, Hepatocellular; Cell Proliferation; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Flavanones; Hep G2 Cells; Humans; Inflammation Mediators; Liver; Liver Neoplasms; Male; Methotrexate; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats | 2020 |
The ameliorative impacts of Moringa oleifera leaf extract against oxidative stress and methotrexate-induced hepato-renal dysfunction.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation; Inflammation Mediators; Kidney; Kidney Diseases; Liver; Male; Methotrexate; Mice; Moringa oleifera; Oxidative Stress; Plant Extracts; Plant Leaves; Signal Transduction | 2020 |
Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma.
Topics: Animals; Antitussive Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bone Marrow; Cell Death; Cholangiocarcinoma; Cholestasis; Disease Models, Animal; Female; HEK293 Cells; Humans; Methotrexate; Mice; Mice, Inbred C57BL; Neutrophils; Perfusion | 2020 |
Metformin alleviates memory and hippocampal neurogenesis decline induced by methotrexate chemotherapy in a rat model.
Topics: Animals; Antimetabolites, Antineoplastic; Disease Models, Animal; Doublecortin Protein; Hippocampus; Hypoglycemic Agents; Male; Memory Disorders; Metformin; Methotrexate; Neurogenesis; Random Allocation; Rats; Rats, Sprague-Dawley | 2020 |
Hepatoprotective effect of rebamipide against methotrexate-induced hepatic intoxication: role of Nrf2/GSK-3β, NF-κβ-p65/JAK1/STAT3, and PUMA/Bax/Bcl-2 signaling pathways.
Topics: Alanine; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Janus Kinase 1; Liver; Male; Methotrexate; Necrosis; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Quinolones; Rats, Wistar; Signal Transduction; STAT3 Transcription Factor; Transcription Factor RelA | 2020 |
Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8
Topics: Animals; Artemisinins; CD8-Positive T-Lymphocytes; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Imiquimod; Immunologic Memory; Interleukin-15; Interleukin-17; Male; Methotrexate; Mice; Psoriasis; Recurrence; Secondary Prevention; Skin; Skin Transplantation; Transplantation Chimera | 2020 |
Effects of nafamostat mesilate on 5-hydroxytryptamine release from isolated ileal tissues induced by anti-cancer drugs in rats.
Topics: Animals; Benzamidines; Cisplatin; Disease Models, Animal; Guanidines; Ileum; Intestine, Small; Male; Methotrexate; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Serotonin | 2020 |
MTX Treatment Does Not Improve Outcome in Mice with AMI.
Topics: Animals; Blood Cell Count; Blood Platelets; Disease Models, Animal; Male; Methotrexate; Mice, Inbred C57BL; Myocardial Infarction; Serum Amyloid P-Component; Systole; Treatment Outcome; Ventricular Function, Left | 2021 |
Refinement and validation of infrared thermal imaging (IRT): a non-invasive technique to measure disease activity in a mouse model of rheumatoid arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Methotrexate; Mice; Reproducibility of Results | 2020 |
Methotrexate Therapy Promotes Cell Coverage and Stability in in-Stent Neointima.
Topics: Anaplastic Lymphoma Kinase; Animals; Apoptosis; Carotid Artery, Common; Cell Proliferation; Disease Models, Animal; Drug-Eluting Stents; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Male; Methotrexate; Neointima; Phosphatidylinositol 3-Kinases; Rabbits; Random Allocation | 2021 |
Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell‑based vaccines in murine colon carcinoma.
Topics: Animals; Cancer Vaccines; Carcinoma; Cell Line, Tumor; Colon; Colonic Neoplasms; Combined Modality Therapy; Dendritic Cells; Disease Models, Animal; Drug Carriers; Female; Humans; Hydroxyethyl Starch Derivatives; Intestinal Mucosa; Methotrexate; Mice; Nanoconjugates; Tumor Escape | 2021 |
Metformin and omega-3 fish oil elicit anti-inflammatory effects via modulation of some dysregulated micro RNAs expression and signaling pathways in experimental induced arthritis.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Arthritis, Experimental; Disease Models, Animal; Drug Therapy, Combination; Fish Oils; Gene Expression Regulation; Hypoglycemic Agents; Interleukin-1beta; Male; Metformin; Methotrexate; MicroRNAs; Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha | 2021 |
In Vitro and In Vivo Efficacy of a Novel Glucose-Methotrexate Conjugate in Targeted Cancer Treatment.
Topics: Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Carriers; Drug Liberation; Drug Screening Assays, Antitumor; Female; Folic Acid; Glucose; Glucose Transporter Type 1; Humans; Injections, Intravenous; Methotrexate; Mice | 2021 |
Protective effect of Coenzyme Q10 on oxidative ovarian and uterine damage induced by methotrexate in rats.
Topics: Animals; Antioxidants; Disease Models, Animal; Female; Humans; Male; Methotrexate; Ovarian Diseases; Oxidative Stress; Protective Agents; Rats; Ubiquinone; Uterine Diseases | 2021 |
Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes.
Topics: Animals; Arthritis, Experimental; Cells, Cultured; Collagen; Disease Models, Animal; Extracellular Vesicles; Female; Forkhead Transcription Factors; Human Umbilical Vein Endothelial Cells; Humans; Immunomodulation; Immunosuppressive Agents; Interleukin-10; Interleukin-17; Mesenchymal Stem Cells; Methotrexate; Nuclear Receptor Subfamily 1, Group F, Member 3; Rats; Rats, Wistar; Synovial Membrane; T-Lymphocytes, Regulatory; Th17 Cells; Transforming Growth Factor beta | 2021 |
CP-25 ameliorates methotrexate induced nephrotoxicity via improving renal apoptosis and methotrexate excretion.
Topics: Acute Kidney Injury; Animals; Apoptosis; Disease Models, Animal; Gene Expression; Glucosides; Kidney; Male; Methotrexate; Molecular Targeted Therapy; Monoterpenes; Organic Anion Transporters, Sodium-Independent; Rats, Sprague-Dawley | 2021 |
Therapeutic effects of vitamin D and IL-22 on methotrexate-induced mucositis in mice.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Gene Transfer Techniques; Inflammation Mediators; Interleukin-22; Interleukins; Intestinal Mucosa; Methotrexate; Mice; Mice, Inbred BALB C; Mucositis; Vitamin D; Weight Loss | 2022 |
Protective Effects of Alpha-Lipoic Acid on Methotrexate-Induced Oxidative Lung Injury in Rats.
Topics: Animals; Antioxidants; Disease Models, Animal; Glutathione; Humans; Interleukin-1beta; Lung; Lung Injury; Male; Malondialdehyde; Methotrexate; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Thioctic Acid; Tumor Necrosis Factor-alpha | 2018 |
Therapeutic effect of quercetin in collagen-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Chemokine CCL2; Collagen; Disease Models, Animal; Inflammation; Interleukin-17; Interleukin-1beta; Joints; Methotrexate; Mice; Mice, Inbred C57BL; Protective Agents; Quercetin; Tumor Necrosis Factor-alpha | 2017 |
Influence of Drugs Carried in Lipid Nanoparticles in Coronary Disease of Rabbit Transplanted Heart.
Topics: Animals; Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Cytokines; Disease Models, Animal; Drug Carriers; Gene Expression Regulation; Graft Rejection; Graft Survival; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Injections, Intravenous; Methotrexate; Myocardium; Nanoparticles; Paclitaxel; Rabbits; Real-Time Polymerase Chain Reaction; RNA | 2017 |
Paroxetine alleviates T lymphocyte activation and infiltration to joints of collagen-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Cell Movement; Chemokine CX3CL1; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 2; Immunosuppressive Agents; Interleukin-1beta; Lymphocyte Activation; Male; Methotrexate; Paroxetine; Rats; Rats, Wistar; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Tumor Necrosis Factor-alpha | 2017 |
mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph
Topics: Animals; Antimetabolites, Antineoplastic; Cell Cycle; Cell Line, Tumor; Disease Models, Animal; DNA Damage; Drug Resistance, Neoplasm; Female; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Mercaptopurine; Methotrexate; Mice; Mice, Knockout; Models, Biological; Philadelphia Chromosome; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays | 2017 |
Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats.
Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; Doxorubicin; Drug Delivery Systems; Head and Neck Neoplasms; Humans; Methotrexate; Nanoparticles; Rats; Squamous Cell Carcinoma of Head and Neck | 2017 |
Effects of polysaccharide fractions isolated from
Topics: Animals; Arthritis; Collagen; Disease Models, Animal; Humans; Immunity, Humoral; Macrophages; Methotrexate; Mice; Phagocytes; Polysaccharides; Ranunculaceae; Sheep | 2017 |
Sustained secretion of anti-tumor necrosis factor α monoclonal antibody from ex vivo genetically engineered dermal tissue demonstrates therapeutic activity in mouse model of rheumatoid arthritis.
Topics: Adalimumab; Animals; Antibodies, Monoclonal; Arthritis, Rheumatoid; Cytokines; Disease Models, Animal; Female; Genetic Engineering; Genetic Therapy; Humans; Male; Methotrexate; Mice; Mice, SCID; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.
Topics: Animals; Arthritis, Experimental; Body Weight; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Gene Expression Regulation; Lipopolysaccharides; Macrophages; Male; Methotrexate; Peptides; Rats; Spleen; Toll-Like Receptor 4; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Drug Carriers; Folate Receptors, GPI-Anchored; Folic Acid; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Male; Methotrexate; Molecular Targeted Therapy; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers; Rats, Sprague-Dawley | 2017 |
Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Topics: Alzheimer Disease; Animals; Biological Transport; Brain; Disease Models, Animal; Drug Delivery Systems; Drug Discovery; Enzyme Inhibitors; Humans; Male; Membrane Transport Proteins; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pharmaceutical Preparations; Tight Junction Proteins; Transcriptome | 2017 |
Anti-psoriatic and toxicity evaluation of methotrexate loaded chitin nanogel in imiquimod induced mice model.
Topics: Aminoquinolines; Animals; Chitin; Disease Models, Animal; Drug Delivery Systems; Humans; Imiquimod; Methotrexate; Mice; Mice, Inbred BALB C; Nanoparticles; Psoriasis; THP-1 Cells | 2018 |
Protective effects of gallic acid against methotrexate-induced toxicity in rats.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Aspartate Aminotransferases; Biomarkers; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gallic Acid; Immunohistochemistry; Liver Function Tests; Male; Methotrexate; Multivariate Analysis; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reference Values; Risk Assessment; Superoxide Dismutase | 2018 |
Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain; Breast Neoplasms; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Female; Fluorouracil; Learning; Memory; Methotrexate; Mice; Mice, Transgenic; Neurogenesis; Organ Size; Receptors, Virus | 2018 |
Vanillin mitigates the adverse impact of cisplatin and methotrexate on rat kidneys.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Benzaldehydes; Biomarkers; Cisplatin; Cytoprotection; Disease Models, Animal; Inflammation Mediators; Kidney; Male; Methotrexate; Nitrosative Stress; Oxidative Stress; Rats, Sprague-Dawley | 2018 |
PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats.
Topics: Animals; Antineoplastic Agents; Cognitive Dysfunction; Dentate Gyrus; Discrimination Learning; Disease Models, Animal; Doublecortin Protein; Enzyme Inhibitors; Female; Fluorouracil; Hippocampus; Humans; Learning; Methotrexate; Neurogenesis; Neuroprotective Agents; Pyridines; Rats; Rats, Long-Evans; Ribonucleotide Reductases; Spatial Memory; Thiosemicarbazones | 2018 |
Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Death; Cell Line; Cell Proliferation; Cell Survival; Disease Models, Animal; Female; Fertility; Gefitinib; Heterografts; Humans; Methotrexate; Mice; Microtubules; Miosis; Placenta; Pregnancy; Pregnancy, Ectopic; Quinazolines; Trophoblasts; Vinblastine; Vinorelbine | 2018 |
Pharmacological characterisation of CR6086, a potent prostaglandin E
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclic AMP; Cytokines; Disease Models, Animal; Drug Therapy, Combination; HEK293 Cells; Humans; Macrophages; Male; Methotrexate; Mice, Inbred DBA; Radioligand Assay; Rats, Inbred Lew; Receptors, Prostaglandin E, EP4 Subtype; THP-1 Cells; Vascular Endothelial Growth Factor A | 2018 |
Ellagic acid as a potential antioxidant, alleviates methotrexate-induced hepatotoxicity in male rats.
Topics: Animals; Antimetabolites, Antineoplastic; Antioxidants; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Ellagic Acid; Glutathione; Immunosuppressive Agents; Liver; Male; Methotrexate; Oxidative Stress; Rats; Rats, Wistar | 2019 |
Abrogation of Hepatic Damage Induced by Anticancer Drug Methotrexate by Zobo (Hibiscus sabdariffa extract) Supplementation via Targeting Oxidative Hepatotoxicity in Rats.
Topics: Animals; Antimetabolites, Antineoplastic; Antioxidants; Chemical and Drug Induced Liver Injury; Dietary Supplements; Disease Models, Animal; Hibiscus; Lipid Peroxidation; Liver; Male; Methotrexate; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar | 2019 |
Notch-1 siRNA and Methotrexate towards a Multifunctional Approach in Rhematoid Arthritis Management: a Nanomedicine Approach.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Combined Modality Therapy; Disease Models, Animal; Drug Carriers; Drug Compounding; Ethylene Oxide; Genetic Therapy; Human Umbilical Vein Endothelial Cells; Humans; Lactones; Methotrexate; Mice; Micelles; Nanomedicine; Polyesters; Polyethylene Glycols; Polyethyleneimine; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Receptor, Notch1; RNA, Small Interfering; Signal Transduction; Synoviocytes; Treatment Outcome | 2018 |
Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cholesterol, Dietary; Cytokines; Disease Models, Animal; Drug Compounding; Drug Therapy, Combination; Inflammation Mediators; Lipids; Liposomes; Male; Matrix Metalloproteinase 9; Methotrexate; Nanoparticles; Paclitaxel; Plaque, Atherosclerotic; Rabbits | 2018 |
Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances.
Topics: Adenosine; Animals; Arthritis, Rheumatoid; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Inflammation; Macrophage Colony-Stimulating Factor; Macrophages; Male; Methotrexate; Mice; Monocytes; Purines; Synovial Fluid | 2018 |
Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats: single-agent effects of alkaline phosphatase and synergistic effects in combination with methotrexate.
Topics: Alkaline Phosphatase; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Models, Animal; Drug Therapy, Combination; Liver; Macrophages; Male; Methotrexate; Positron Emission Tomography Computed Tomography; Rats, Wistar; Recombinant Proteins; Spleen; Synovial Membrane; Tissue Distribution | 2018 |
Methotrexate and BAFF interaction prevents immunization against TNF inhibitors.
Topics: 5'-Nucleotidase; Adenosine; Animals; Antibody Formation; Antigens, CD; Apyrase; Autoimmune Diseases; B-Cell Activating Factor; B-Lymphocytes; Disease Models, Animal; Drug Resistance; Humans; Immunization; Macaca; Methotrexate; Mice; Mice, Transgenic; Tumor Necrosis Factor-alpha | 2018 |
Commiphora molmol protects against methotrexate-induced nephrotoxicity by up-regulating Nrf2/ARE/HO-1 signaling.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidant Response Elements; Commiphora; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Free Radical Scavengers; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Inflammation Mediators; Kidney; Lipid Peroxidation; Male; Methotrexate; NF-E2-Related Factor 2; Oxidative Stress; Phytotherapy; Plants, Medicinal; Rats, Wistar; Resins, Plant; Signal Transduction | 2018 |
Induction and Amelioration of Methotrexate-Induced Gastrointestinal Toxicity are Related to Immune Response and Gut Microbiota.
Topics: Animals; Bacteria; Bacteroides fragilis; Caco-2 Cells; Dendritic Cells; Disease Models, Animal; Gastrointestinal Diseases; Gastrointestinal Microbiome; Humans; Macrophages; Male; Methotrexate; Mice; Phylogeny; RAW 264.7 Cells; Time Factors | 2018 |
Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment.
Topics: Animals; Brain; Cell Differentiation; Cell Lineage; Cognitive Dysfunction; Disease Models, Animal; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Methotrexate; Mice; Microglia; Myelin Sheath; Nerve Fibers, Myelinated; Neurogenesis; Neuroglia; Neurons; Oligodendroglia; White Matter | 2019 |
Cytoprotective effects of molsidomine against methotrexate-induced hepatotoxicity: an experimental rat study.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Lipid Peroxidation; Liver; Male; Methotrexate; Molsidomine; Oxidative Stress; Rats, Wistar | 2019 |
Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion.
Topics: Animals; Cell Death; Cell Line, Tumor; Cell-Derived Microparticles; Disease Models, Animal; Endocytosis; Humans; Lung Neoplasms; Methotrexate; Mice, Inbred C57BL; Neoplasm Staging; Pleural Effusion, Malignant; Tissue Distribution; Transplantation, Autologous; Tumor Microenvironment | 2019 |
Combination leflunomide and methotrexate impedes the recovery of liver fibrosis, partly through inhibition of myeloid cell admittance.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Collagen Type III; Collagen Type IV; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Female; Hepatic Stellate Cells; Humans; Hyaluronic Acid; Laminin; Leflunomide; Liver Cirrhosis; Male; Methotrexate; Mice; Monocytes; Myeloid Cells; Vascular Endothelial Growth Factor A | 2019 |
Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway.
Topics: Animals; Blotting, Western; Cell Proliferation; Dermatologic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Hesperidin; Humans; Imiquimod; Keratinocytes; Lipopolysaccharides; Male; MAP Kinase Signaling System; Methotrexate; Mice; Mice, Inbred BALB C; Psoriasis; Real-Time Polymerase Chain Reaction | 2019 |
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model.
Topics: Administration, Topical; Animals; Disease Models, Animal; Drug Carriers; Gold; Immunosuppressive Agents; Metal Nanoparticles; Methotrexate; Mice; Mice, Inbred C57BL; Psoriasis; Sulfhydryl Compounds | 2019 |
Preventive and therapeutic effects of aqueous extract of Spinacia oleracea on Psoriatic patches in albino rats.
Topics: Animals; Dermatologic Agents; Disease Models, Animal; Female; Male; Methotrexate; Plant Extracts; Potassium Iodide; Psoriasis; Rats; Severity of Illness Index; Skin; Solvents; Spinacia oleracea; Water | 2019 |
cis-Khellactone Inhibited the Proinflammatory Macrophages via Promoting Autophagy to Ameliorate Imiquimod-Induced Psoriasis.
Topics: Adjuvants, Immunologic; Animals; Autophagy; Autophagy-Related Protein 7; Beclin-1; Cells, Cultured; Coumarins; Disease Models, Animal; Female; Gene Knockdown Techniques; Hepatocytes; Humans; Imiquimod; Macrophages; Male; Methotrexate; Mice; Mice, Inbred C57BL; Primary Cell Culture; Psoriasis; Toxicity Tests | 2019 |
Venlafaxine alleviates complete Freund's adjuvant-induced arthritis in rats: Modulation of STAT-3/IL-17/RANKL axis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Biomarkers; Disease Models, Animal; Freund's Adjuvant; Interleukin-17; Interleukin-6; Male; Matrix Metalloproteinase 3; Methotrexate; NF-kappa B; Oxidative Stress; RANK Ligand; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2019 |
Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model.
Topics: Animals; Arthritis, Experimental; Collagen; Disease Models, Animal; Folic Acid; Folic Acid Antagonists; Male; Methotrexate; Mice; Polyglutamic Acid | 2019 |
Orally administered salecan ameliorates methotrexate-induced intestinal mucositis in mice.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antioxidants; beta-Glucans; Disease Models, Animal; Free Radical Scavengers; Immunity, Innate; Intestinal Mucosa; Male; Metabolomics; Methotrexate; Mice; Mice, Inbred C57BL; Mucositis; Oxidative Stress | 2019 |
Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive Impairment.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Channelrhodopsins; Cognition Disorders; Disease Models, Animal; Humans; Immunosuppressive Agents; Luminescent Proteins; Membrane Glycoproteins; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelin Sheath; Oligodendrocyte Precursor Cells; Organic Chemicals; Protein-Tyrosine Kinases; Recognition, Psychology; Signal Transduction; Urea | 2019 |
Protocatechuic acid inhibits testicular and epididymal toxicity associated with methotrexate in rats.
Topics: Animals; Dietary Supplements; Disease Models, Animal; Epididymis; Humans; Hydroxybenzoates; Lipid Peroxidation; Male; Methotrexate; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Spermatogenesis; Testicular Diseases; Testis | 2019 |
Serine and 1-carbon metabolism are required for HIF-mediated protection against retinopathy of prematurity.
Topics: Animals; Carbon; Disease Models, Animal; Glycine; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolines; Liver; Metabolic Networks and Pathways; Methotrexate; Mice; Mice, Knockout; Oxygen; Protein Stability; Retina; Retinopathy of Prematurity; Serine; Tissue Culture Techniques; Up-Regulation | 2019 |
Intravitreal injection of methotrexate in an experimental rabbit model: determination of ultrastructural changes.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Female; Follow-Up Studies; Immunosuppressive Agents; Intravitreal Injections; Male; Methotrexate; Microscopy, Electron; Rabbits; Retina; Retinal Diseases | 2013 |
Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Enzyme Activation; Female; Gene Silencing; Humans; Melanoma; Methotrexate; Methylation; Mice; Myosin Heavy Chains; Myosin Type V; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 2C; Protein Transport; Proto-Oncogene Proteins c-akt; Signal Transduction; Staurosporine; Xenograft Model Antitumor Assays | 2013 |
Flaviviruses are sensitive to inhibition of thymidine synthesis pathways.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Dengue Virus; Disease Models, Animal; DNA Viruses; Flavivirus; Flavivirus Infections; Floxuridine; HEK293 Cells; HeLa Cells; Humans; Leucovorin; Methotrexate; Mice; Mice, 129 Strain; Mice, Inbred C57BL; RNA Viruses; Thymidine; Tumor Suppressor Protein p53; Vero Cells; Virus Replication; West Nile virus | 2013 |
Role of methotrexate exposure in apoptosis and proliferation during early neurulation.
Topics: Animals; Apoptosis; Caspase 3; Cell Proliferation; Disease Models, Animal; Down-Regulation; Embryonic Development; Epithelial Cells; Female; Folic Acid; Folic Acid Antagonists; Folic Acid Deficiency; Histones; Methotrexate; Mice; Mice, Inbred C57BL; Microarray Analysis; Neural Tube Defects; Neurulation; Pregnancy; Tetrahydrofolate Dehydrogenase; Up-Regulation | 2014 |
Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit.
Topics: Animals; Anti-Inflammatory Agents; Citrus paradisi; Colitis; Dextran Sulfate; Disease Models, Animal; Drug Delivery Systems; Gene Expression Regulation; Heme Oxygenase-1; Humans; Inflammatory Bowel Diseases; Interleukin-1beta; Intestinal Mucosa; Macrophages; Male; Methotrexate; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Nanostructures; Plant Extracts; Tumor Necrosis Factor-alpha | 2014 |
Methotrexate treatment causes early onset of disease in a mouse model of Ross River virus-induced inflammatory disease through increased monocyte production.
Topics: Alphavirus Infections; Animals; Antirheumatic Agents; Arthritis; CD11b Antigen; Disease Models, Animal; Inflammation; Inflammation Mediators; Methotrexate; Mice; Monocytes; Muscle, Skeletal; Ross River virus | 2013 |
Carrier-free functionalized multidrug nanorods for synergistic cancer therapy.
Topics: Animals; Camptothecin; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Carriers; Drug Synergism; Drug Therapy, Combination; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; KB Cells; MCF-7 Cells; Methotrexate; Mice; Mice, Inbred BALB C; Nanoparticles; Nanotubes; Neoplasms; Paclitaxel | 2013 |
Evaluation of therapeutic efficacy of Majoon Suranjan, a Unani formulation, in the treatment of rheumatoid arthritis: an experimental study.
Topics: Animals; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cattle; Collagen Type II; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Male; Medicine, Unani; Methotrexate; Phytotherapy; Rats; Rats, Wistar; Rheumatoid Factor | 2013 |
Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy.
Topics: Administration, Topical; Animals; Combined Modality Therapy; Disease Models, Animal; Humans; Liposomes; Methotrexate; Mice, Inbred Strains; Nanospheres; Orthokeratologic Procedures; Parakeratosis; Photochemotherapy; Psoriasis; Trioxsalen; Ultraviolet Therapy | 2014 |
Investigation of effect of nutritional drink on chemotherapy-induced mucosal injury and tumor growth in an established animal model.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Beverages; Body Weight; Cell Proliferation; Diarrhea; Diet; Disease Models, Animal; Female; Goblet Cells; Methotrexate; Mucositis; Neoplasms; Nutritional Status; Random Allocation; Rats | 2013 |
Glutamine supplementation, but not combined glutamine and arginine supplementation, improves gut barrier function during chemotherapy-induced intestinal mucositis in rats.
Topics: Animals; Arginine; Dietary Supplements; Disease Models, Animal; Gastrointestinal Tract; Glutamine; Immunohistochemistry; Intestines; Male; Methotrexate; Mucositis; NF-kappa B; Occludin; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2014 |
Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Methotrexate; Plant Extracts; Plant Roots; Powders; Rats; Rats, Wistar; Severity of Illness Index; Withania | 2014 |
Mitochondrial dysfunction and respiratory chain defects in a rodent model of methotrexate-induced enteritis.
Topics: Animals; Cell Survival; Disease Models, Animal; Electron Transport; Electron Transport Chain Complex Proteins; Enteritis; Enterocytes; Intestine, Small; Male; Methotrexate; Mitochondria; Mitochondrial Diseases; Peroxynitrous Acid; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Time Factors; Weight Loss | 2014 |
The efficacy of minocycline against methotrexate-induced pulmonary fibrosis in mice.
Topics: Animals; Antioxidants; Catalase; Cytoprotection; Disease Models, Animal; Lung; Malondialdehyde; Methotrexate; Mice; Minocycline; Oxidative Stress; Pulmonary Fibrosis; Time Factors | 2013 |
Analyses of copy number variation reveal putative susceptibility loci in MTX-induced mouse neural tube defects.
Topics: Animals; Chromatography, Liquid; Comparative Genomic Hybridization; Disease Models, Animal; DNA Copy Number Variations; Folic Acid; Gene Expression Profiling; Genetic Predisposition to Disease; Leucovorin; Methotrexate; Mice, Inbred C57BL; MicroRNAs; Neural Tube Defects; Real-Time Polymerase Chain Reaction; S-Adenosylmethionine; Tandem Mass Spectrometry; Tetrahydrofolate Dehydrogenase; Tetrahydrofolates | 2014 |
The effect of methotrexate on the bone healing of mandibular condylar process fracture: an experimental study in rats.
Topics: Alkaline Phosphatase; Animals; Atrophy; Bone Remodeling; Bone Resorption; Bony Callus; Cartilage, Articular; Connective Tissue; Disease Models, Animal; Fibrocartilage; Fracture Healing; Immunosuppressive Agents; Injections, Intraperitoneal; Male; Mandibular Condyle; Mandibular Fractures; Methotrexate; Osteogenesis; Random Allocation; Rats; Rats, Wistar; Temporomandibular Joint; Tissue Survival | 2014 |
Prediction of antiarthritic drug efficacies by monitoring active matrix metalloproteinase-3 (MMP-3) levels in collagen-induced arthritic mice using the MMP-3 probe.
Topics: Animals; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Collagen; Disease Models, Animal; Infliximab; Matrix Metalloproteinase 3; Methotrexate; Mice; Molecular Probes | 2014 |
1-Methyl-tryptophan synergizes with methotrexate to alleviate arthritis in a mouse model of arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Autoimmunity; Cytokines; Disease Models, Animal; Drug Synergism; Inflammation; Methotrexate; Mice; Tryptophan; Tryptophan Oxygenase | 2014 |
Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis.
Topics: Animals; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Feces; Kidney; Liver; Male; Methotrexate; Multidrug Resistance-Associated Protein 2; Non-alcoholic Fatty Liver Disease; Rats, Sprague-Dawley; Tissue Distribution | 2014 |
Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats.
Topics: Acetylcysteine; Amifostine; Animals; Antioxidants; Ascorbic Acid; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Liver; Male; Methotrexate; Oxidative Stress; Rats, Sprague-Dawley; Time Factors | 2014 |
Systems level metabolic phenotype of methotrexate administration in the context of non-alcoholic steatohepatitis in the rat.
Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Energy Metabolism; Folic Acid; Liver; Magnetic Resonance Spectroscopy; Male; Metabolomics; Methotrexate; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats, Sprague-Dawley; Tissue Distribution | 2014 |
Effect of methotrexate upon antigen-induced arthritis of the rabbit temporomandibular joint.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Cartilage, Articular; Disease Models, Animal; Female; Inflammation; Injections, Intra-Articular; Methotrexate; Ovalbumin; Rabbits; Random Allocation; Temporomandibular Joint; Temporomandibular Joint Disorders | 2015 |
The effect of colchicine and low-dose methotrexate on intestinal ischemia/reperfusion injury in an experimental model.
Topics: Animals; Anti-Inflammatory Agents; Colchicine; Disease Models, Animal; Ileal Diseases; Intestines; Male; Methotrexate; Rats; Rats, Wistar; Reperfusion Injury | 2014 |
Therapeutic effects of micheliolide on a murine model of rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cytokines; Disease Models, Animal; Female; Immunosuppressive Agents; Male; Methotrexate; Mice; Sesquiterpenes, Guaiane | 2015 |
The role of Wnt/β-catenin signaling in enterocyte turnover during methotrexate-induced intestinal mucositis in a rat.
Topics: Animals; Apoptosis; beta Catenin; Caco-2 Cells; Cell Proliferation; Disease Models, Animal; Enterocytes; Humans; Intestinal Mucosa; Intestines; Male; Methotrexate; Mucositis; Rats; Rats, Sprague-Dawley; Wnt Signaling Pathway | 2014 |
Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Experimental; B-Lymphocytes; Cells, Cultured; Collagen; Cytokines; Disease Models, Animal; Humans; In Vitro Techniques; Inflammation; Interferon-gamma; Interleukin-2; Janus Kinases; Mast Cells; Methotrexate; Mice; Mice, Inbred DBA; Protein Kinase Inhibitors; Rats; Rats, Inbred Lew; Signal Transduction; T-Lymphocytes | 2015 |
New formulated "DOX-MTX-loaded nanoparticles" down- regulate HER2 gene expression and improve the clinical outcome in OSCCs model in rat: the effect of IV and oral modalities.
Topics: Administration, Oral; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chi-Square Distribution; Disease Models, Animal; Down-Regulation; Doxorubicin; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Infusions, Intravenous; Male; Methotrexate; Molecular Targeted Therapy; Mouth Neoplasms; Nanoparticles; Neoplasms, Experimental; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Treatment Outcome | 2014 |
Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Infarction; Brain Ischemia; Disease Models, Animal; Etoposide; Exercise Test; Ifosfamide; Intracranial Thrombosis; Lasers; Locomotion; Male; Methotrexate; Mice; Mice, Inbred Strains; Movement Disorders; Rotarod Performance Test; Wakefulness | 2015 |
Protective effects of aqueous extract of Solanum nigrum Linn. leaves in rat models of oral mucositis.
Topics: Animals; Body Weight; Busulfan; Chromatography, High Pressure Liquid; Disease Models, Animal; Feeding Behavior; Female; Methotrexate; Phytochemicals; Phytotherapy; Plant Extracts; Plant Leaves; Protective Agents; Rats, Wistar; Solanum nigrum; Stomatitis; Survival Analysis; Toxicity Tests, Acute; Water | 2014 |
Olmesartan decreased levels of IL-1β and TNF-α, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Bacteremia; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Down-Regulation; Imidazoles; Immunohistochemistry; Interleukin-1beta; Intestine, Small; Leukocytosis; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Methotrexate; Mucositis; RANK Ligand; Rats; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Tetrazoles; Tumor Necrosis Factor-alpha; Up-Regulation | 2014 |
Sugarcane bagasse lignin, and silica gel and magneto-silica as drug vehicles for development of innocuous methotrexate drug against rheumatoid arthritis disease in albino rats.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Cellulose; Disease Models, Animal; Drug Carriers; Knee Joint; Magnetic Fields; Male; Methotrexate; Rats; Saccharum; Silica Gel | 2015 |
Methotrexate induced apoptotic and necrotic chromatin changes in rat myeloid leukemia cells.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Apoptosis; Bone Marrow Cells; Cell Cycle; Cells, Cultured; Chromatin; Disease Models, Animal; DNA Packaging; Dose-Response Relationship, Drug; Leukemia, Myeloid; Male; Methotrexate; Rats; Rats, Long-Evans | 2015 |
Effects of silymarin on methotrexate-induced nephrotoxicity in rats.
Topics: Animals; Antimetabolites, Antineoplastic; Antioxidants; Disease Models, Animal; Kidney Diseases; Male; Methotrexate; Rats; Rats, Sprague-Dawley; Silymarin | 2015 |
Efficacy of parenteral administration of bee venom in experimental arthritis in the rat: a comparison with methotrexate.
Topics: Aminopeptidases; Animals; Antirheumatic Agents; Arthritis, Experimental; Bee Venoms; CD13 Antigens; Cyanosis; Dipeptidyl Peptidase 4; Disease Models, Animal; Edema; Hyperalgesia; Inflammation; Leukocytes, Mononuclear; Male; Methotrexate; Pain; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2015 |
Defining immunological impact and therapeutic benefit of mild heating in a murine model of arthritis.
Topics: Animals; Antibodies; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Combined Modality Therapy; Cytokines; Disease Models, Animal; Heat-Shock Proteins; Hyperthermia, Induced; Joints; Macrophage Activation; Macrophages; Methotrexate; Mice; NF-kappa B; STAT1 Transcription Factor; T-Lymphocytes | 2015 |
Genomic DNA hypomethylation is associated with neural tube defects induced by methotrexate inhibition of folate metabolism.
Topics: Animals; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; DNA Methylation; Embryonic Development; Female; Folic Acid; Folic Acid Antagonists; Folic Acid Deficiency; Methotrexate; Mice; Neural Tube Defects; Pregnancy; Protein Serine-Threonine Kinases; Tandem Mass Spectrometry; Ubiquitin-Protein Ligases; Wnt Signaling Pathway | 2015 |
Effects of pentoxifylline and alpha lipoic acid on methotrexate-induced damage in liver and kidney of rats.
Topics: Animals; Antioxidants; Biomarkers; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Kidney Diseases; Male; Methotrexate; Pentoxifylline; Rats; Rats, Sprague-Dawley; Thioctic Acid | 2015 |
In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Diarrhea; Disease Models, Animal; Imidazoles; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestine, Small; Male; Methotrexate; Mucositis; Neoplasms; Olmesartan Medoxomil; Rats, Wistar; Sucrose; Tetrazoles; Tumor Necrosis Factor-alpha; Weight Loss | 2015 |
Therapeutic effect of methotrexate encapsulated in cationic liposomes (EndoMTX) in comparison to free methotrexate in an antigen-induced arthritis study in vivo.
Topics: Administration, Intravenous; Animals; Antigens, Bacterial; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Blood Platelets; Capsules; Cell Communication; Disease Models, Animal; Endothelial Cells; Female; Knee Joint; Leukocytes; Liposomes; Methotrexate; Mice; Mice, Inbred C57BL; Microcirculation; Radiography; Treatment Outcome | 2015 |
DC-Based Immunotherapy Combined with Low-Dose Methotrexate Effective in the Treatment of Advanced CIA in Mice.
Topics: Animals; Antigens, Surface; Arthritis, Experimental; Coculture Techniques; Dendritic Cells; Disease Models, Animal; Female; Immune Tolerance; Immunophenotyping; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy, Adoptive; Lymphoid Tissue; Methotrexate; Mice; Phenotype; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells | 2015 |
Prevention of methotrexate-induced nephrotoxicity by concomitant administration of garlic aqueous extract in rat.
Topics: Adenosine Deaminase; Animals; Calcium; Catalase; Creatinine; Disease Models, Animal; Garlic; Glutathione; Kidney Diseases; Male; Malondialdehyde; Methotrexate; Nitric Oxide; Phosphorus; Plant Extracts; Potassium; Rats; Rats, Wistar; Sodium; Urea | 2015 |
Effect of minimal enteral feeding on recovery in a methotrexate-induced gastrointestinal mucositis rat model.
Topics: Animals; Antimetabolites, Antineoplastic; Citrulline; Disease Models, Animal; Enteral Nutrition; Humans; Intestinal Mucosa; Male; Methotrexate; Mucositis; Rats; Rats, Wistar | 2016 |
Can pretreatment serum calcium level predict the efficacy of methotrexate in the treatment of severe plaque psoriasis?
Topics: Adolescent; Adult; Aged; Animals; Area Under Curve; Biomarkers; Calcium; Cohort Studies; Disease Models, Animal; Female; Humans; Male; Methotrexate; Mice; Middle Aged; Predictive Value of Tests; Psoriasis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |
Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment.
Topics: Animals; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Cell Line; Chemistry, Pharmaceutical; Dexamethasone; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Humans; Immunohistochemistry; Injections, Intra-Articular; Male; Methotrexate; Mice; Rats; Spectroscopy, Near-Infrared; X-Ray Microtomography | 2015 |
Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
Topics: Animals; Arthritis, Rheumatoid; Chronic Disease; Disease Models, Animal; Drug Carriers; Humans; Inflammation; Interferon-gamma; Interleukin-17; Lipids; Methotrexate; Nanocapsules; Rats; Synovial Membrane; T-Lymphocytes | 2015 |
Apoptosome activation, an important molecular instigator in 6-mercaptopurine induced Leydig cell death.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Apoptosomes; Caspases; Cell Line, Tumor; Disease Models, Animal; Humans; Leydig Cells; Male; Mercaptopurine; Methotrexate; Mice, Transgenic; Multidrug Resistance-Associated Proteins; Reactive Oxygen Species | 2015 |
Anti-inflammatory effects of intravenous methotrexate associated with lipid nanoemulsions on antigen-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Disease Models, Animal; Injections, Intra-Articular; Joints; Leukocyte Count; Methotrexate; Nanoparticles; Neutrophils; Rabbits; Synovial Fluid; Synovial Membrane | 2016 |
Methotrexate up-regulates ecto-5'-nucleotidase/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment.
Topics: 5'-Nucleotidase; Adenosine Monophosphate; Animals; Brain Neoplasms; Cell Line, Tumor; Chromatography, High Pressure Liquid; Disease Models, Animal; Glioblastoma; Immunohistochemistry; Immunosuppressive Agents; Methotrexate; Rats; T-Lymphocytes; Tumor Escape; Tumor Microenvironment; Up-Regulation | 2016 |
Steamed root of Rehmannia glutinosa Libosch (Plantaginaceae) alleviates methotrexate-induced intestinal mucositis in rats.
Topics: Animals; Disease Models, Animal; Female; Glutathione; Intestinal Mucosa; Methotrexate; Mucositis; Plant Preparations; Plant Roots; Plantaginaceae; Rats; Rats, Wistar; Rehmannia; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Weight Loss | 2016 |
Effect of caffeic acid phenethyl ester on oxidant and anti-oxidant status of liver and serum in a rat model with acute methanol intoxication.
Topics: Animals; Antioxidants; Caffeic Acids; Disease Models, Animal; Ethanol; Liver; Male; Methanol; Methotrexate; Oxidants; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley | 2017 |
APL-1, an altered peptide ligand derived from heat-shock protein, alone or combined with methotrexate attenuates murine collagen-induced arthritis.
Topics: Animals; Arthritis, Experimental; Disease Models, Animal; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Heat-Shock Proteins; Immunologic Factors; Interleukin-10; Male; Methotrexate; Mice, Inbred DBA; Peptides; Severity of Illness Index; T-Lymphocytes, Regulatory; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Ultrasonographical assessment of implanted biodegradable device for long-term slow release of methotrexate into the vitreous.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Chitosan; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Immunosuppressive Agents; Methotrexate; Polyesters; Rabbits; Retina; Ultrasonography; Vitreous Body | 2016 |
Successful intestinal Echinococcus multilocularis oncosphere invasion and subsequent hepatic metacestode establishment in resistant RccHan™:WIST rats after pharmacological immunosuppression.
Topics: Animals; Dexamethasone; Disease Models, Animal; Disease Resistance; Echinococcosis; Echinococcosis, Hepatic; Echinococcus multilocularis; Immunosuppression Therapy; Immunosuppressive Agents; Intestines; Methotrexate; Ovum; Rats; Rats, Nude; Rats, Wistar; T-Lymphocytes | 2016 |
Environmental enrichment protects against cognitive impairment following chemotherapy in an animal model.
Topics: Animals; Antimetabolites, Antineoplastic; Cognition Disorders; Disease Models, Animal; Drug Therapy; Environment; Female; Fluorouracil; Hippocampus; Methotrexate; Neurogenesis; Rats; Rats, Long-Evans; Spatial Memory | 2016 |
Protective Effects of Vitamin E on Methotrexate-Induced Jejunal Mucosal Damage in Rats.
Topics: Animals; Antioxidants; Biomarkers; Cytoprotection; Disease Models, Animal; Gastrointestinal Hemorrhage; Glutathione Peroxidase; Intestinal Mucosa; Jejunal Diseases; Jejunum; Male; Malondialdehyde; Methotrexate; Necrosis; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Rats, Wistar; Superoxide Dismutase; Time Factors; Vitamin E | 2016 |
Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model.
Topics: Administration, Cutaneous; Animals; Arthritis, Experimental; Cell Survival; Cytokines; Disease Models, Animal; Female; Humans; Inflammation; Lipids; Methotrexate; Nanostructures; Rats; Rats, Wistar | 2016 |
18β-Glycyrrhetinic acid protects against methotrexate-induced kidney injury by up-regulating the Nrf2/ARE/HO-1 pathway and endogenous antioxidants.
Topics: Acute Kidney Injury; Animals; Biomarkers; Carboxylic Ester Hydrolases; Disease Models, Animal; Gap Junctions; Glycyrrhetinic Acid; Heme Oxygenase (Decyclizing); Kidney; Lipid Peroxidation; Male; Methotrexate; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA; Up-Regulation | 2016 |
Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver.
Topics: Animals; Arachidonate Lipoxygenases; Arthritis, Experimental; Biomarkers; C-Reactive Protein; Cytokines; Disease Models, Animal; Gene Expression Regulation; Inflammation Mediators; Liver; Male; Methotrexate; Organ Specificity; Rats; Serotonin; Severity of Illness Index; Time Factors; Transcriptome | 2016 |
Effects of Methotrexate in a Rabbit Model of In-Stent Neoatherosclerosis: An Optical Coherence Tomography Study.
Topics: Animals; Atherosclerosis; Carotid Artery Diseases; Cytokines; Disease Models, Animal; Drug-Eluting Stents; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Male; Methotrexate; NF-kappa B; Rabbits; Reproducibility of Results; Stents; Tomography, Optical Coherence | 2016 |
Scavenger Receptor-Mediated Targeted Treatment of Collagen-Induced Arthritis by Dextran Sulfate-Methotrexate Prodrug.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Dextran Sulfate; Disease Models, Animal; Histocytochemistry; Knee Joint; Macrophages; Methotrexate; Mice; Mice, Inbred DBA; Prodrugs; RAW 264.7 Cells; Receptors, Scavenger; Treatment Outcome | 2017 |
Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer.
Topics: Adenocarcinoma; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antimetabolites, Antineoplastic; Chemokines; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Immunotherapy, Adoptive; Injections, Intraperitoneal; Injections, Intravenous; Interleukin-2 Receptor alpha Subunit; Lectins, C-Type; Lymphocyte Activation; Mammary Neoplasms, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Transgenic; T-Cell Antigen Receptor Specificity; T-Lymphocytes, Cytotoxic; Thy-1 Antigens | 2008 |
Pre-bled-young-rats in genotoxicity testing: a model for peripheral blood micronucleus assay.
Topics: Animals; Area Under Curve; Diethylnitrosamine; Disease Models, Animal; Hemorrhage; Male; Methotrexate; Mice; Micronucleus Tests; Mutagenicity Tests; Mutagens; Quercetin; Rats; Rats, Sprague-Dawley; Reticulocytes; Streptozocin; Time Factors; Zidovudine | 2008 |
Methotrexate-loaded polymethylmethacrylate bone cement for local bone metastasis therapy: pilot animal study in the rabbit patellar groove.
Topics: Animals; Bone Cements; Bone Neoplasms; Disease Models, Animal; Methotrexate; Patella; Pilot Projects; Polymethyl Methacrylate; Prostheses and Implants; Rabbits | 2008 |
Plasmodium berghei: lack of antimalarial activity of an analogue of folate precursor, 2,4-diamino-6-hydroxymethylpteridine in a mouse model.
Topics: Aminopterin; Animals; Antimalarials; Disease Models, Animal; Folic Acid Antagonists; Malaria; Male; Methotrexate; Mice; Mice, Inbred ICR; Parasitemia; Plasmodium berghei; Pteridines; Random Allocation | 2008 |
Transforming growth factor-alpha stimulates enterocyte proliferation and accelerates intestinal recovery following methotrexate-induced intestinal mucositis in a rat and a cell culture model.
Topics: Animals; Caco-2 Cells; Cell Proliferation; Disease Models, Animal; Enterocytes; Humans; Intercellular Signaling Peptides and Proteins; Intestinal Mucosa; Male; Methotrexate; Mucositis; Noxae; Rats; Rats, Sprague-Dawley; Recovery of Function; Transforming Growth Factor alpha | 2008 |
Leptin accelerates enterocyte turnover during methotrexate-induced intestinal mucositis in a rat.
Topics: Animals; Annexin A5; Apoptosis; bcl-2-Associated X Protein; Caco-2 Cells; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocytes; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Ileum; Intestinal Mucosa; Jejunum; Leptin; Male; Methotrexate; Mucositis; Organ Size; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function; RNA, Messenger; Time Factors | 2009 |
Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats.
Topics: Analysis of Variance; Animals; Antimetabolites, Antineoplastic; Association Learning; Cell Death; Cell Proliferation; Cognition; Cognition Disorders; Conditioning, Classical; Disease Models, Animal; Fear; Follow-Up Studies; Hippocampus; Maze Learning; Methotrexate; Rats; Rats, Wistar; Time Factors | 2009 |
Locomotion and muscle mass measures in a murine model of collagen-induced arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Body Weight; Cachexia; Disability Evaluation; Disease Models, Animal; Disease Progression; Gait Disorders, Neurologic; Image Processing, Computer-Assisted; Locomotion; Male; Methotrexate; Mice; Mice, Inbred DBA; Muscle, Skeletal; Muscular Atrophy; Severity of Illness Index; Treatment Outcome; Video Recording | 2009 |
Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer.
Topics: Animals; Antineoplastic Agents; Cisplatin; Disease Models, Animal; Disease Progression; Methotrexate; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Survival Analysis | 2010 |
Therapeutic and preventive effects of methotrexate on zymosan-induced arthritis in SKG mice.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Female; Immunohistochemistry; Methotrexate; Mice; Mice, Inbred BALB C; Random Allocation | 2009 |
Ozone ameliorates methotrexate-induced intestinal injury in rats.
Topics: Animals; Disease Models, Animal; Glutathione Peroxidase; Ileum; Intestinal Diseases; Kidney; Liver; Malondialdehyde; Methotrexate; Oxidative Stress; Ozone; Rats | 2009 |
Dietary zinc supplementation and methotrexate-induced small intestinal mucositis in metallothionein-knockout and wild-type mice.
Topics: Animals; Dietary Supplements; Disease Models, Animal; Intestine, Small; Male; Metallothionein; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Knockout; Mucositis; Zinc | 2009 |
Optimization of the non-invasive 13C-sucrose breath test in a rat model of methotrexate-induced mucositis.
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Breath Tests; Carbon Isotopes; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Female; Intestine, Small; Methotrexate; Mucositis; Organ Size; Rats; Sensitivity and Specificity; Sucrase; Sucrose | 2010 |
Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant).
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Combined Modality Therapy; Disease Models, Animal; Escherichia coli; Humans; Male; Methotrexate; Probiotics; Rats; Rats, Inbred Lew | 2009 |
Effects of methotrexate on plasma cytokines and cardiac remodeling and function in postmyocarditis rats.
Topics: Animals; Collagen Type I; Collagen Type III; Cytokines; Disease Models, Animal; Heart; Immunosuppressive Agents; Interleukin-10; Interleukin-6; Male; Methotrexate; Myocarditis; Rats; Rats, Inbred Lew; Swine; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2009 |
Methotrexate has no antifibrotic effect in bleomycin-induced experimental scleroderma.
Topics: Animals; Antirheumatic Agents; Bleomycin; Disease Models, Animal; Fibrosis; Injections, Intraperitoneal; Methotrexate; Mice; Mice, Inbred BALB C; Scleroderma, Systemic; Skin; Treatment Outcome | 2010 |
Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.
Topics: Animals; Antimetabolites, Antineoplastic; Behavior, Animal; Cisterna Magna; Cognition Disorders; Disease Models, Animal; Folic Acid; Folic Acid Antagonists; Homocysteine; Inflammation Mediators; Injections, Spinal; Male; Memory Disorders; Methotrexate; Motor Activity; Neuropsychological Tests; Psychomotor Performance; Rats; Rats, Long-Evans; Recognition, Psychology; Time Factors | 2010 |
Effects of in vitro exposure of Echinococcus multilocularis metacestodes to cytostatic drugs on in vivo growth and proliferation of the parasite.
Topics: Animals; Anthelmintics; Autopsy; Body Weight; Cytostatic Agents; Disease Models, Animal; Echinococcosis; Echinococcus multilocularis; Female; Gerbillinae; Magnetic Resonance Imaging; Male; Methotrexate; Vinblastine; Vincristine; Vinorelbine | 2010 |
Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
Topics: Administration, Topical; Animals; Dermatologic Agents; Diffusion Chambers, Culture; Disease Models, Animal; Drug Combinations; Drug Synergism; Gels; Humans; Immunodiffusion; Liposomes; Male; Menthol; Methotrexate; Parakeratosis; Permeability; Psoriasis; Rats; Rats, Wistar; Skin; Skin Absorption; Tissue Culture Techniques | 2011 |
Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro.
Topics: Animals; Apoptosis; Blood Cell Count; Bone Marrow; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Fibroblasts; Hydroxyproline; Immunohistochemistry; In Situ Nick-End Labeling; Lung; Male; Methotrexate; Mice; Mice, Inbred C57BL; Pulmonary Alveoli; Pulmonary Fibrosis | 2010 |
Investigation of kinetics of methotrexate for therapeutic treatment of intraocular lymphoma.
Topics: Animals; Disease Models, Animal; Drug Delivery Systems; Eye Neoplasms; Humans; Immunosuppressive Agents; Lymphoma; Methotrexate; Models, Biological; Rabbits; Treatment Outcome; Vitreous Body | 2010 |
Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation.
Topics: Animals; Arthritis; Cytokines; Disease Models, Animal; DNA; Endodeoxyribonucleases; Lymphocytes; Macrophages; Methotrexate; Mice; Mice, Knockout | 2010 |
Formation of reactive oxygen and nitrogen species in the presence of pinosylvin - an analogue of resveratrol.
Topics: Animals; Antioxidants; Antirheumatic Agents; Arthritis, Experimental; Cell Line; Disease Models, Animal; Drug Therapy, Combination; Macrophages; Male; Methotrexate; Neutrophils; Nitric Oxide; Rats; Rats, Inbred Lew; Reactive Oxygen Species; Resveratrol; Stilbenes | 2010 |
Carnosine inhibits degradation of hyaluronan induced by free radical processes in vitro and improves the redox imbalance in adjuvant arthritis in vivo.
Topics: Animals; Antioxidants; Antirheumatic Agents; Arthritis, Experimental; Carnosine; Disease Models, Animal; Free Radicals; Glutathione; Hyaluronic Acid; In Vitro Techniques; Male; Methotrexate; Oxidation-Reduction; Protein Carbonylation; Rats; Rats, Inbred Lew; Thiobarbituric Acid Reactive Substances | 2010 |
The effect of methotrexate on corneal neovascularization in rabbits.
Topics: Administration, Topical; Animals; Antimetabolites, Antineoplastic; Cornea; Corneal Neovascularization; Disease Models, Animal; Interleukin-6; Methotrexate; Rabbits; Treatment Outcome; Vascular Endothelial Growth Factor A | 2011 |
Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow.
Topics: Adipocytes; Adipogenesis; Animals; Antimetabolites, Antineoplastic; Bone Diseases, Metabolic; Bone Marrow Cells; Cell Differentiation; Disease Models, Animal; Male; Methotrexate; Osteogenesis; Rats; Rats, Sprague-Dawley; Stem Cells | 2012 |
Intestinal inflammation influences α-MSH reactive autoantibodies: relevance to food intake and body weight.
Topics: alpha-MSH; Animals; Anorexia; Autoantibodies; Body Weight; Disease Models, Animal; Drinking; Eating; Humans; Immunoglobulin G; Male; Methotrexate; Mucositis; Rabbits; Rats; Rats, Sprague-Dawley | 2012 |
Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Dendrimers; Disease Models, Animal; Female; Folate Receptor 1; Head and Neck Neoplasms; Humans; Methotrexate; Mice; Mice, SCID; Molecular Targeted Therapy; Neoplasm Transplantation | 2011 |
Synergistic activity of curcumin with methotrexate in ameliorating Freund's Complete Adjuvant induced arthritis with reduced hepatotoxicity in experimental animals.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Arthritis, Experimental; Aspartate Aminotransferases; Bilirubin; Curcumin; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Female; Freund's Adjuvant; Lipid Peroxidation; Liver; Methotrexate; Organ Size; Rats; Rats, Wistar | 2011 |
Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Cognition Disorders; Cues; Disease Models, Animal; Donepezil; Female; Fluorouracil; Indans; Maze Learning; Memory; Methotrexate; Mice; Mice, Inbred BALB C; Nootropic Agents; Piperidines; Space Perception; Time Factors | 2011 |
Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist.
Topics: Animals; Cognition Disorders; Dextromethorphan; Disease Models, Animal; Excitatory Amino Acid Antagonists; Folic Acid; Glutamic Acid; Homocysteine; Humans; Injections, Spinal; Male; Memory Disorders; Methotrexate; Rats; Rats, Long-Evans; Recognition, Psychology | 2011 |
Protective effect of pentoxyfilline in renal toxicity after methotrexate administration.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Blood Urea Nitrogen; Creatinine; Cytoprotection; Disease Models, Animal; Glutathione Peroxidase; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Methotrexate; Pentoxifylline; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Polymerized-type I collagen induces upregulation of Foxp3-expressing CD4 regulatory T cells and downregulation of IL-17-producing CD4⁺ T cells (Th17) cells in collagen-induced arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; CD4 Antigens; Collagen Type I; Disease Models, Animal; Disease Progression; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Immunomodulation; Immunotherapy; Interleukin-17; Joints; Methotrexate; Mice; Mice, Inbred DBA; Polymerization; T-Lymphocytes, Regulatory; Th17 Cells | 2012 |
Methothrexate attenuates early neutrophil infiltration and the associated lipid peroxidation in the injured spinal cord but does not induce neurotoxicity in the uninjured spinal cord in rats.
Topics: Animals; Anti-Inflammatory Agents; Chemotaxis, Leukocyte; Disease Models, Animal; Female; Immunosuppressive Agents; Lipid Peroxidation; Methotrexate; Neutrophil Infiltration; Rats; Rats, Wistar; Spinal Cord Injuries | 2012 |
Facial symmetry evaluation after experimentally displaced condylar process fracture in methotrexate treated rats.
Topics: Analysis of Variance; Animals; Body Weight; Cephalometry; Disease Models, Animal; Facial Asymmetry; Immunosuppressive Agents; Joint Dislocations; Male; Mandibular Condyle; Mandibular Fractures; Maxilla; Methotrexate; Radiography; Random Allocation; Rats; Rats, Wistar; Temporomandibular Joint Disorders | 2012 |
The effects of chemotherapy on cognitive function in a mouse model: a prospective study.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cognition; Disease Models, Animal; Female; Fluorouracil; Learning; Longitudinal Studies; Memory; Methotrexate; Mice; Mice, Inbred BALB C; Neuropsychological Tests; Prospective Studies; Time Factors | 2012 |
Interleukin-6 regulates anti-arthritic effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model.
Topics: Animals; Arthritis, Experimental; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Interleukin-6; Male; Methotrexate; Mice; Mice, Inbred DBA; Reduced Folate Carrier Protein; Treatment Outcome | 2012 |
Non-Fas(CD95/APO1)-mediated apoptosis of activated T cells inhibits the development of atherosclerosis.
Topics: Animals; Aorta, Thoracic; Apoptosis; Atherosclerosis; Cholesterol; Disease Models, Animal; fas Receptor; Immunity, Cellular; Immunomodulation; Immunosuppressive Agents; Male; Methotrexate; Mice; Mice, Inbred C57BL; Prognosis | 2012 |
Immunomodulatory effect of sertraline in a rat model of rheumatoid arthritis.
Topics: Analysis of Variance; Animals; Arthritis, Rheumatoid; Concanavalin A; Cyclooxygenase 2; Cytokines; Cytotoxicity Tests, Immunologic; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Freund's Adjuvant; Immunologic Factors; Methotrexate; Rats; Rats, Inbred Lew; Sertraline; Spleen; Thymidine | 2012 |
Efficacy of concurrent administration of cilostazol and methotrexate in rheumatoid arthritis: pharmacologic and clinical significance.
Topics: Animals; Antirheumatic Agents; Apoptosis; Arthritis, Rheumatoid; Base Sequence; Cell Proliferation; Cells, Cultured; Cilostazol; Cytokines; Disease Models, Animal; DNA Primers; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Male; Methotrexate; Mice; Mice, Inbred DBA; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles | 2012 |
Inhibition of sumoylation prevents experimental fibrosis.
Topics: Adolescent; Adult; Animals; Disease Models, Animal; Female; Fibroblasts; Fibrosis; Gene Knockdown Techniques; Humans; Immunosuppressive Agents; Keratinocytes; Male; Methotrexate; Mice; Middle Aged; Receptors, Transforming Growth Factor beta; RNA, Small Interfering; Scleroderma, Systemic; Signal Transduction; Skin; Smad3 Protein; SUMO-1 Protein; Sumoylation; Ubiquitin-Conjugating Enzymes; Young Adult | 2012 |
Acute and chronic inflammation studies of Strobilanthes callosus leaves extract on rat model.
Topics: Acanthaceae; Acute Disease; Administration, Oral; Analysis of Variance; Animals; Anti-Inflammatory Agents; Carrageenan; Chronic Disease; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Male; Methotrexate; Plant Extracts; Plant Leaves; Prednisolone; Rats; Rats, Wistar; Solvents | 2013 |
Effects of shark cartilage polysaccharides on the secretion of IL-6 and IL-12 in rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cartilage; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Inflammation Mediators; Interleukin-12; Interleukin-6; Joints; Macrophages, Peritoneal; Male; Methotrexate; Polysaccharides; Rats; Rats, Wistar; Sharks; Time Factors | 2012 |
The role of zinc on anti-Newcastle disease virus specific antibody response and agranulocytes count in rabbits treated with methotrexate and prednisolone.
Topics: Administration, Oral; Animals; Antibodies, Viral; Disease Models, Animal; Female; Granulocytes; Immunosuppressive Agents; Injections, Subcutaneous; Leukocyte Count; Male; Methotrexate; Newcastle disease virus; Prednisolone; Rabbits; Time Factors; Viral Vaccines; Zinc | 2012 |
Methotrexate induces germ cell apoptosis and impairs spermatogenesis in a rat.
Topics: Abortifacient Agents, Nonsteroidal; Analysis of Variance; Animals; Apoptosis; Blotting, Western; Disease Models, Animal; In Situ Nick-End Labeling; Male; Methotrexate; Rats; Rats, Sprague-Dawley; Spermatogenesis; Spermatozoa | 2013 |
Preclinical drug evaluation system in the Plasmodium knowlesi baboon model of malaria: the methotrexate study.
Topics: Animals; Antimalarials; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Malaria; Male; Methotrexate; Papio anubis; Parasitemia; Plasmodium knowlesi | 2013 |
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats.
Topics: Adenosine; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Humans; Inflammation; Longitudinal Studies; Lymphocytes; Male; Methotrexate; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Receptors, Purinergic P1; Rituximab; Tumor Necrosis Factor-alpha; Up-Regulation | 2013 |
Effects of methotrexate upon inflammatory parameters induced by carrageenan in the mouse model of pleurisy.
Topics: Adenosine Deaminase; Animals; Carrageenan; Disease Models, Animal; Female; Immunosuppressive Agents; Male; Methotrexate; Mice; Nitric Oxide; Peroxidase; Pleura; Pleurisy | 2002 |
Decreased activity of hepatic P-glycoprotein in the isolated perfused liver of the adjuvant arthritis rat.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromatography, High Pressure Liquid; Disease Models, Animal; Doxorubicin; Female; Kinetics; Liver; Methotrexate; Perfusion; Rats; Rats, Inbred Lew; Time Factors | 2002 |
Evaluation of the protective effect of methotrexate on OK432-induced liver injury in a rat model.
Topics: Animals; Chi-Square Distribution; Cholangitis; Disease Models, Animal; Methotrexate; Picibanil; Rats; Statistics, Nonparametric | 2003 |
Effect of immunostimulatory ribomunyl on the preventive treatment of rat adjuvant arthritis with cyclosporine and methotrexate.
Topics: Administration, Oral; Animals; Antigens, Bacterial; Arthritis, Experimental; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Immunosuppressive Agents; Inflammation Mediators; Male; Methotrexate; Random Allocation; Rats; Rats, Inbred Lew; Reference Values; Sensitivity and Specificity; Treatment Outcome | 2003 |
Translocation model of Candida albicans in DBA-2/J mice with protein calorie malnutrition mimics hematogenous candidiasis in humans.
Topics: Animals; Candida albicans; Candidiasis; Cyclophosphamide; Disease Models, Animal; Feces; Female; Fungemia; Humans; Immunosuppressive Agents; Intestinal Mucosa; Intestines; Leukopenia; Liver; Methotrexate; Mice; Mice, Inbred DBA; Protein-Energy Malnutrition; Specific Pathogen-Free Organisms | 2003 |
Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Topics: Animals; Arthritis, Experimental; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; Enzyme-Linked Immunosorbent Assay; Female; Hindlimb; Immunosuppressive Agents; Interleukin-1; Interleukin-6; Methotrexate; Rats; Rats, Inbred Lew; Tacrolimus; Tumor Necrosis Factor-alpha | 2003 |
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies.
Topics: Adolescent; Animals; Antineoplastic Agents; Child; Child, Preschool; Dexamethasone; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Gene Rearrangement, T-Lymphocyte; Genes, Immunoglobulin; Humans; Immunophenotyping; Male; Methotrexate; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasms, Experimental; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Heterologous; Treatment Outcome; Vincristine | 2004 |
Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Disease Models, Animal; Dose-Response Relationship, Drug; Duodenum; Eating; Ileum; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Methotrexate; Potassium; Rats; Rats, Wistar; Sodium; Stomatitis; Water; Weight Loss | 2004 |
Effect of MX-68 on airway inflammation and hyperresponsiveness in mice and guinea-pigs.
Topics: 2-Aminoadipic Acid; Acetylcholine; Administration, Inhalation; Allergens; Animals; Body Weight; Bronchial Hyperreactivity; Bronchitis; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Immunoglobulins; Injections, Intraperitoneal; Interferon-gamma; Interleukin-4; Interleukin-5; Male; Methotrexate; Mice; Mice, Inbred BALB C; Ovalbumin; Prednisolone | 2004 |
Lactoferrin reduces methotrexate-induced small intestinal damage, possibly through inhibition of GLP-2-mediated epithelial cell proliferation.
Topics: Animals; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Caco-2 Cells; Cell Division; Cells, Cultured; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Female; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Humans; Intestinal Mucosa; Lactoferrin; Methotrexate; Peptides; Polymerase Chain Reaction; Rats; Rats, Inbred Strains | 2004 |
Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX.
Topics: Animals; Antibodies; Antigens, CD; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Collagen; Collagen Type II; Disease Models, Animal; Drug Administration Schedule; Drug Carriers; Drug Combinations; Drug Synergism; Flow Cytometry; Humans; Injections, Intravenous; Leukocytes, Mononuclear; Male; Methotrexate; Mice; Mice, Inbred DBA; Serum Albumin; Treatment Outcome | 2004 |
Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity.
Topics: Age of Onset; Animals; Anti-Inflammatory Agents; Azathioprine; Disease Models, Animal; Disease Progression; Dogs; Female; Glucocorticoids; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Narcolepsy; Nucleic Acid Synthesis Inhibitors; Severity of Illness Index; Sleep; Time Factors; Treatment Outcome | 2004 |
In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Biomarkers; Collagen; Disease Models, Animal; Endopeptidases; Fluorescence; Histocytochemistry; Male; Methotrexate; Mice; Mice, Inbred DBA; Sensitivity and Specificity; Treatment Outcome | 2004 |
Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Collagen Type II; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Fibroblasts; Immunosuppressive Agents; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID | 2005 |
Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Chronic Disease; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Interleukin-1; Interleukin-6; Joints; Male; Methotrexate; Mice; Mice, Inbred DBA; p38 Mitogen-Activated Protein Kinases; Prednisolone; Terpenes; Tumor Necrosis Factor-alpha | 2004 |
A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat.
Topics: Analysis of Variance; Animals; Breath Tests; Disease Models, Animal; Injections, Subcutaneous; Intestinal Mucosa; Intestine, Small; Male; Methotrexate; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Sucrose | 2004 |
Eisai hyperbilirubinemic rat (EHBR) as an animal model affording high drug-exposure in toxicity studies on organic anions.
Topics: Animals; Anions; Area Under Curve; ATP-Binding Cassette Transporters; Blood Proteins; Creatine Kinase; Disease Models, Animal; Folic Acid Antagonists; Half-Life; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbilirubinemia; Male; Methotrexate; Muscle, Skeletal; Pravastatin; Protein Binding; Rats; Rats, Inbred Strains; Toxicity Tests; Weight Gain | 2004 |
[The effects of interleukin-11 on high-dose methotrexate (HDMTX) induced mucositis in Wistar rats].
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Interleukin-11; Intestinal Mucosa; Intestine, Small; Male; Methotrexate; Microscopy, Electron; Mucositis; Proliferating Cell Nuclear Antigen; Random Allocation; Rats; Rats, Wistar; Survival Rate | 2004 |
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.
Topics: Animals; Antineoplastic Agents; Carrier Proteins; Dendrimers; Disease Models, Animal; Drug Carriers; Female; Fluorescent Dyes; Folate Receptors, GPI-Anchored; Humans; KB Cells; Methotrexate; Mice; Mice, Nude; Mice, SCID; Nanostructures; Polyamines; Radiopharmaceuticals; Receptors, Cell Surface; Tissue Distribution; Tritium; Xenograft Model Antitumor Assays | 2005 |
Application of anti-methotrexate Fab fragments for the optimization of intraperitoneal methotrexate therapy in a murine model of peritoneal cancer.
Topics: Animals; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Area Under Curve; Body Weight; Combined Modality Therapy; Disease Models, Animal; Half-Life; Immunoglobulin Fab Fragments; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Male; Maximum Tolerated Dose; Methotrexate; Mice; Peritoneal Neoplasms; Sarcoma 180; Survival Rate | 2005 |
Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation.
Topics: Acute Disease; Adenosine; Air; Animals; Anti-Inflammatory Agents; Carrageenan; Chromosome Mapping; Disease Models, Animal; Drug Resistance; Exudates and Transudates; Inbreeding; Inflammation; Injections, Subcutaneous; Methotrexate; Mice; Mice, Inbred Strains; Osmolar Concentration; Phenotype; Quantitative Trait Loci | 2005 |
Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis.
Topics: Abatacept; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Models, Animal; Drug Therapy, Combination; Humans; Immunoconjugates; Immunologic Factors; Infusions, Intravenous; Lymphocyte Activation; Methotrexate; Randomized Controlled Trials as Topic; T-Lymphocytes | 2005 |
M-VAC regimen in murine bladder tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Models, Animal; Doxorubicin; Female; Methotrexate; Mice; Mice, Inbred C3H; Urinary Bladder Neoplasms; Vinblastine | 1989 |
Methotrexate causes oxidative stress in rat kidney tissues.
Topics: Animals; Biomarkers; Disease Models, Animal; Female; Glutathione Peroxidase; Infusions, Intravenous; Kidney; Lipid Peroxidation; Malondialdehyde; Methotrexate; Oxidative Stress; Probability; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Superoxide Dismutase; Tissue Culture Techniques | 2005 |
Artemether: a new therapeutic strategy in experimental rheumatoid arthritis.
Topics: Animals; Antibodies; Antimalarials; Antirheumatic Agents; Artemether; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Bone and Bones; Cell Line, Tumor; Cell Survival; Collagen Type II; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Injections, Intramuscular; Injections, Intraperitoneal; Joints; Male; Matrix Metalloproteinase 2; Methotrexate; Mice; Nitric Oxide; Rats; Rats, Inbred Lew; Time Factors | 2005 |
The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma.
Topics: Aminopterin; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cytarabine; Deoxycytidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Gemcitabine; Humans; In Vitro Techniques; Lymphoma, Non-Hodgkin; Methotrexate; Mice; Mice, SCID; Time Factors; Xenograft Model Antitumor Assays | 2006 |
Low-dose methotrexate inhibits lung metastasis and lengthens survival in rat osteosarcoma.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Division; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Rats; Rats, Inbred F344; Survival Analysis | 2005 |
Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.
Topics: Animals; Colony Count, Microbial; Dexamethasone; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Folic Acid Antagonists; Glucocorticoids; Injections; Methotrexate; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vitreous Body | 2006 |
Seizure-promoting effect of blood-brain barrier disruption.
Topics: Adult; Animals; Antineoplastic Agents; Biomarkers; Blood-Brain Barrier; Brain; Brain Neoplasms; Cerebrovascular Disorders; Disease Models, Animal; Electroencephalography; Female; Functional Laterality; Humans; Infusions, Intra-Arterial; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Osmotic Pressure; S100 Proteins; Seizures; Swine; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats.
Topics: Adolescent; Adult; Amides; Animals; Arachidonic Acids; Atrophy; Cannabinoid Receptor Modulators; Case-Control Studies; Celiac Disease; Child; Diet, Protein-Restricted; Disease Models, Animal; Duodenum; Endocannabinoids; Ethanolamines; Female; Glycerides; Humans; Jejunum; Male; Methotrexate; Middle Aged; Palmitic Acids; Peroxidase; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Time Factors; Up-Regulation | 2007 |
Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction.
Topics: Amino Acid Sequence; Animals; Anion Transport Proteins; Cell Membrane; Disease Models, Animal; Folic Acid; Folic Acid Antagonists; Folic Acid Deficiency; HeLa Cells; Humans; Hydrogen-Ion Concentration; Intestine, Small; Kinetics; Male; Membrane Potentials; Membrane Transport Proteins; Methotrexate; Mice; Mice, Inbred C57BL; Microvilli; Molecular Sequence Data; Oocytes; Polyglutamic Acid; Protein Structure, Secondary; Protein Structure, Tertiary; Protein Transport; Proton-Coupled Folate Transporter; Rats; RNA, Messenger; Tetrahydrofolates; Xenopus | 2007 |
Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model.
Topics: alpha-Glucosidases; Animals; Disease Models, Animal; Dose-Response Relationship, Immunologic; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Glycogen Storage Disease Type II; Immune Tolerance; Immunoglobulin G; Immunosuppressive Agents; Injections, Intraperitoneal; Injections, Intravenous; Male; Methotrexate; Mice; Mice, Knockout; Recombinant Proteins | 2008 |
Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.
Topics: Acute Disease; Animals; Antibodies; CD3 Complex; Chronic Disease; Colitis; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-12 Subunit p40; Methotrexate; Mice; Mice, Inbred C57BL | 2008 |
Gene expression profiles of murine fatty liver induced by the administration of methotrexate.
Topics: Administration, Oral; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Liver; Gene Expression; Gene Expression Profiling; Lipid Metabolism; Male; Methotrexate; Mice; Mice, Inbred ICR; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Toxicogenetics | 2008 |
Effects of cytotoxic drugs on proliferative vitreoretinopathy in the rabbit cell injection model.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Doxorubicin; Eye Diseases; Female; Fibroblasts; Fluorouracil; Male; Methotrexate; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone; Trifluridine; Vitreous Body | 1984 |
Induction of an experimental phenylketonuria-like condition in infant rats during the first 2 weeks after birth.
Topics: Animals; Animals, Newborn; Diet; Disease Models, Animal; Female; Fenclonine; Humans; Male; Methotrexate; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Tyrosine | 1981 |
Systemic chemotherapy of murine bladder cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Line; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Etoposide; FANFT; Female; Methotrexate; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Urinary Bladder Neoplasms | 1984 |
The Nb rat prostatic adenocarcinoma's dose response to methotrexate and adriamycin.
Topics: Adenocarcinoma; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Male; Methotrexate; Neoplasm Metastasis; Prostatic Neoplasms; Rats | 1983 |
An experimental model to determine the effects of adjuvant therapy on the incidence of postoperative wound infection: II. Evaluating preoperative chemotherapy.
Topics: Animals; Disease Models, Animal; Head and Neck Neoplasms; Humans; Lethal Dose 50; Leucovorin; Leukocyte Count; Male; Methotrexate; Preoperative Care; Radiotherapy, High-Energy; Rats; Staphylococcal Infections; Surgical Wound Infection; Time Factors; Wound Healing | 1980 |
Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cricetinae; Cyclophosphamide; Disease Models, Animal; Fluorouracil; Guinea Pigs; Male; Mesocricetus; Methotrexate; Mitomycin; Mitomycins; Neoplasms, Experimental; Pancreatic Neoplasms; Vincristine | 1982 |
Chemoimmunotherapy of murine bladder cancer.
Topics: Animals; BCG Vaccine; Carcinoma, Transitional Cell; Cyclophosphamide; Disease Models, Animal; Drug Therapy, Combination; Female; Methotrexate; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Urinary Bladder Neoplasms | 1981 |
Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors.
Topics: Animals; Brain Neoplasms; Disease Models, Animal; Drug Delivery Systems; Evaluation Studies as Topic; Glioma; Magnetics; Male; Methotrexate; Microspheres; Rats; Rats, Inbred F344; Solutions; Tissue Distribution | 1995 |
[Studies on biphasic animal model of asthma--lymphocytes and eosinophils].
Topics: Animals; Asthma; Disease Models, Animal; Eosinophils; Guinea Pigs; Lung; Lymphocytes; Methotrexate | 1993 |
Interactions of steroid, methotrexate, and radiation determine neurotoxicity in an animal model to study therapy for childhood leukemia.
Topics: Animals; Behavior, Animal; Brain; Child; Combined Modality Therapy; Disease Models, Animal; Drug Interactions; Female; Humans; Leukemia, Experimental; Male; Methotrexate; Nervous System; Prednisolone; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley | 1994 |
In vivo experimental models on the evaluation of haemoperfusion.
Topics: Alkalosis; Animals; Chlorides; Disease Models, Animal; Female; Hemoperfusion; Male; Methotrexate; Partial Thromboplastin Time; Poisoning; Pyloric Stenosis; Rabbits; Swine; Uremia | 1993 |
Suppression of adjuvant-induced arthritis by liposomally conjugated methotrexate in the rat.
Topics: Animals; Arthritis, Infectious; Disease Models, Animal; Drug Carriers; Liposomes; Male; Methotrexate; Mycobacterium; Phosphatidylethanolamines; Rats; Rats, Inbred Lew; Severity of Illness Index | 1994 |
The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.
Topics: Adenosine; Adenosine Deaminase; Aminoimidazole Carboxamide; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Disease Models, Animal; Female; Inflammation; Kinetics; Leukocytes; Methotrexate; Mice; Mice, Inbred BALB C; Purinergic P1 Receptor Antagonists; Ribonucleotides; Spleen; Theobromine; Time Factors | 1993 |
A rabbit model for the evaluation of minimal access treatment of ectopic pregnancy in humans, using intrachorionic injection and local hyperthermia.
Topics: Abortifacient Agents; Abortion, Therapeutic; Animals; Carbon Dioxide; Chorion; Decidua; Disease Models, Animal; Female; Fever; Hysterectomy; Injections; Methotrexate; Microscopy, Electron; Ornipressin; Pregnancy; Pregnancy, Ectopic; Progesterone; Rabbits; Sodium Chloride; Uterus | 1993 |
Pharmacokinetics and biodistribution of methotrexate conjugated to mannosyl human serum albumin.
Topics: Animals; Disease Models, Animal; Humans; In Vitro Techniques; Leishmaniasis, Visceral; Liver; Macrophages; Mannose; Methotrexate; Mice; Mice, Inbred BALB C; Serum Albumin; Subcellular Fractions; Tissue Distribution | 1993 |
The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain.
Topics: Animals; Brain Neoplasms; Disease Models, Animal; Male; Methotrexate; Microdialysis; Rats; Rhabdomyosarcoma | 1995 |
Vitamin A deficiency exacerbates methotrexate-induced jejunal injury in rats.
Topics: Administration, Oral; alpha-Glucosidases; Animals; Antimetabolites, Antineoplastic; Avitaminosis; Body Weight; Diarrhea; Disaccharides; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Food, Fortified; Incidence; Intestinal Mucosa; Jejunal Diseases; Jejunum; Liver; Male; Methotrexate; Rats; Rats, Wistar; Sucrase; Vitamin A | 1997 |
Cytokine manipulation by methotrexate treatment in murine experimental systemic lupus erythematosus.
Topics: Animals; Cytokines; Disease Models, Animal; Female; Immunosuppressive Agents; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-4; Lupus Erythematosus, Systemic; Methotrexate; Mice; Mice, Inbred BALB C | 1997 |
Preventive effect of a novel antifolate, MX-68, in murine systemic lupus erythematosus (SLE).
Topics: 2-Aminoadipic Acid; Age Factors; Animals; Autoantibodies; Blood Urea Nitrogen; Cholesterol; Chronic Disease; Disease Models, Animal; Female; Folic Acid Antagonists; Graft vs Host Disease; Lupus Erythematosus, Systemic; Lupus Nephritis; Methotrexate; Mice; Mice, Inbred DBA; Mice, Inbred NZB; Proteinuria | 1997 |
The effects of high-dose methotrexate on the development of cartilage lesions in a lapine model of osteoarthrosis.
Topics: Animals; Antirheumatic Agents; Cartilage, Articular; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Intramuscular; Knee Joint; Methotrexate; Osteoarthritis; Rabbits | 1998 |
Effect of methotrexate on distraction osteogenesis.
Topics: Animals; Antimetabolites, Antineoplastic; Blood Cell Count; Bone Neoplasms; Bone Regeneration; Calcification, Physiologic; Calcium; Disease Models, Animal; External Fixators; Female; Humans; Ilizarov Technique; Methotrexate; Osteogenesis, Distraction; Osteosarcoma; Phosphorus; Placebos; Rabbits; Radiography; Random Allocation; Tibia | 1998 |
DNA levels in immune complexes circulating in mice with induced systemic lupus erythematosus.
Topics: Animals; Antigen-Antibody Complex; Disease Models, Animal; DNA; Female; Humans; Lupus Erythematosus, Systemic; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nucleic Acid Synthesis Inhibitors; Tamoxifen | 1999 |
Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy.
Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Disease Models, Animal; Dogs; Female; Male; Methotrexate; Ondansetron; Vomiting | 1999 |
Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cattle; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Hindlimb; Interleukin-1; Lipopolysaccharides; Liposomes; Macrophages, Peritoneal; Methotrexate; Phosphatidylethanolamines; Rats; Rats, Inbred Lew; Time Factors | 1999 |
Topical application of methotrexate for inhibition of corneal angiogenesis.
Topics: Animals; Aqueous Humor; Cell Division; Corneal Neovascularization; Disease Models, Animal; Endothelium, Vascular; Fibroblast Growth Factors; Follow-Up Studies; Immunosuppressive Agents; Methotrexate; Ophthalmic Solutions; Rabbits; Treatment Outcome | 1999 |
Polymer chemotherapy for head and neck cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biodegradation, Environmental; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Cisplatin; Disease Models, Animal; Drug Carriers; Head and Neck Neoplasms; Humans; Methotrexate; Mice; Mice, Nude; Polymers | 2000 |
Central administration of methotrexate reduces mechanical allodynia in an animal model of radiculopathy/sciatica.
Topics: Animals; Disease Models, Animal; Genes, MHC Class II; Glial Fibrillary Acidic Protein; Hindlimb; Immunosuppressive Agents; Male; Methotrexate; Pain Threshold; Radiculopathy; Rats; Rats, Sprague-Dawley; Sciatica; Spinal Cord; Spinal Nerve Roots | 2000 |
A preclinical model for experimental chemotherapy of human head and neck cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Body Weight; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Disease Models, Animal; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Ifosfamide; Methotrexate; Mice; Mice, Nude; Paclitaxel; Survival Rate; Taxoids | 2001 |
Simplified method of heterotopic rat heart transplantation using the cuff technique: application to sublethal dose protocol of methotrexate on allograft survival.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Graft Rejection; Graft Survival; Heart Transplantation; Male; Methotrexate; Microsurgery; Rats; Rats, Inbred Lew; Sensitivity and Specificity; Survival Rate; Transplantation Immunology; Transplantation, Heterologous | 2001 |
MTX affects inflammation and tissue destruction differently in the rat AA model.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Joints; Methotrexate; Rats; Rats, Inbred Lew | 2001 |
Polyglutamation of a novel antifolate, MX-68, is not necessary for its anti-arthritic effect.
Topics: 2-Aminoadipic Acid; Animals; Antineoplastic Agents; Antirheumatic Agents; Arthritis, Experimental; Cell Division; Cells, Cultured; Disease Models, Animal; Folic Acid Antagonists; Male; Methotrexate; Mice; Mice, Inbred DBA; Peptide Synthases; Polyglutamic Acid; Rats; Rats, Inbred Lew; Substrate Specificity; Tetrahydrofolate Dehydrogenase | 2002 |
Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Atrophy; Cell Cycle; Cell Death; Disease Models, Animal; Epithelial Cells; Female; Immunosuppressive Agents; Intestine, Small; Methotrexate; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta2; Weight Loss | 2002 |
Chemotherapeutic remissions in Wistar Furth rat acute myelogenous leukemia: a model for human AML.
Topics: Animals; Antineoplastic Agents; Busulfan; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Dexamethasone; Disease Models, Animal; Doxorubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Methotrexate; Rats; Remission, Spontaneous; Vinblastine; Vincristine | 1977 |
Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
Topics: Animals; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Leucovorin; Leukemia L1210; Methotrexate; Mice; Mice, Inbred Strains; Sarcoma 180; Time Factors | 1978 |
[Effect of cyclophosphamide on experimental tuberculosis in mice].
Topics: Acute Disease; Animals; BCG Vaccine; Chronic Disease; Cyclophosphamide; Disease Models, Animal; Isoniazid; Methotrexate; Mice; Mycobacterium bovis; Tuberculosis | 1978 |
Approaches to graft-versus-host disease following bone marrow transplantation in monkeys and man.
Topics: Adult; Animals; Bone Marrow Transplantation; Cell Separation; Disease Models, Animal; Graft vs Host Disease; Haplorhini; Humans; Immunosuppression Therapy; Leukemia; Lymphocytes; Methotrexate; Middle Aged; Pulmonary Fibrosis; Transplantation, Autologous; Transplantation, Homologous | 1978 |
The use of marmosets (Callithrix jacchus) in teratological and toxicological research.
Topics: Abnormalities, Drug-Induced; Animals; Callitrichinae; Disease Models, Animal; Female; Fetus; Haplorhini; Maternal-Fetal Exchange; Methotrexate; Pregnancy; Pregnancy, Animal; Research; Toxicology; Uterus | 1978 |
Chemotherapy of experimental metastatic brain tumors in female Wistar rats.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carcinoma 256, Walker; Carotid Arteries; Cells, Cultured; Cyclophosphamide; Disease Models, Animal; Female; Lomustine; Methotrexate; Neoplasm Metastasis; Neoplasms, Experimental; Nitrosourea Compounds; Procarbazine; Rats; Semustine | 1979 |
Treatment of meningeal neoplasms.
Topics: Adult; Animals; Antineoplastic Agents; Brain Neoplasms; Carcinoma 256, Walker; Catheterization; Child; Cytarabine; Disease Models, Animal; Drug Therapy, Combination; Humans; Injections, Intraventricular; Injections, Spinal; Leukemia; Lumbosacral Region; Meninges; Methotrexate; Rats; Spinal Cord Neoplasms | 1977 |
New preclinical models for testing antitumor drugs. The immuno-chemotherapy index.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Disease Models, Animal; Doxorubicin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Histocompatibility Antigens; Methotrexate; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Isogeneic | 1978 |
Nonessential role of neutrophils as mediators of hyperacute cardiac allograft rejection in the rat.
Topics: Animals; Blood Platelets; Cyclophosphamide; Disease Models, Animal; Globulins; Graft Rejection; Heart Transplantation; Hypersensitivity; Mast Cells; Methotrexate; Neutrophils; Rabbits; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Skin; Transplantation, Homologous | 1976 |
Mouse myeloma. A model for studies of cell kinetics.
Topics: Alkylating Agents; Animals; Bone Marrow; Bone Marrow Cells; Bone Neoplasms; Cell Division; Cells, Cultured; Cyclophosphamide; Cytarabine; Disease Models, Animal; Kinetics; Melphalan; Methotrexate; Mice; Mice, Inbred BALB C; Myeloma Proteins; Neoplasms, Experimental; Plasmacytoma; Thymidine; Tritium; Vinblastine; Vincristine | 1975 |
[Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions].
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cricetinae; Cyclophosphamide; Dactinomycin; Daunorubicin; Disease Models, Animal; DNA, Neoplasm; Doxorubicin; Drug Evaluation, Preclinical; Female; Fluorouracil; Humans; Hydroxyurea; Male; Methotrexate; Mice; Procarbazine; Rats; RNA, Neoplasm; Time Factors; Triaziquone; Vincristine | 1975 |
The role of neutrophils in acute and chronic inflammation in rats.
Topics: Acute Disease; Animals; Arthritis, Experimental; Carrageenan; Chronic Disease; Disease Models, Animal; Edema; Freund's Adjuvant; Histamine; Inflammation; Leukocyte Count; Male; Methotrexate; Neutropenia; Neutrophils; Rats; Rats, Wistar | 1992 |
Effect of supplemental dietary glutamine on methotrexate concentrations in tumors.
Topics: Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Energy Intake; Glutamine; Humans; Male; Methotrexate; Rats; Rats, Inbred F344; Sarcoma, Experimental | 1992 |
Long-term treatment of the MRL/lpr mouse with methotrexate and 10-deazaaminopterin.
Topics: Aminopterin; Animals; Autoimmune Diseases; Blood Urea Nitrogen; Dermatitis; Disease Models, Animal; Female; Joints; Lymph Nodes; Methotrexate; Mice; Proteinuria | 1992 |
Fatal systemic candidiasis of gastrointestinal origin: an experimental model in mice compromised by anti-cancer treatment.
Topics: Animals; Candida albicans; Candidiasis; Cecum; Chemotherapy, Adjuvant; Disease Models, Animal; Esophagus; Female; Fluorouracil; Follow-Up Studies; Gastrointestinal Diseases; Immunocompromised Host; Intestines; Liver; Methotrexate; Mice; Mice, Inbred ICR; Neoplasms; Stomach; Viscera | 1992 |
[Experimental histological study of the local toxicity of intra-tubal injections of methotrexate].
Topics: Animals; Biopsy; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Infertility, Female; Inflammation; Injections; Injections, Subcutaneous; Methotrexate; Peritoneal Diseases; Pregnancy; Pregnancy, Tubal; Rabbits | 1992 |
Efficacy of bimolane in the Malassezia ovalis model of psoriasis.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Betamethasone Valerate; Disease Models, Animal; Female; Injections, Intravenous; Malassezia; Methotrexate; Psoriasis; Rabbits; Razoxane; Skin | 1991 |
Inhibition of human renal cancer by monoclonal-anti-body-linked methotrexate in an ascites tumor model.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Ehrlich Tumor; Carcinoma, Renal Cell; Cell Division; Disease Models, Animal; Female; Humans; Immunoglobulin G; Immunotoxins; Kidney Neoplasms; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Tumor Cells, Cultured | 1991 |
Effect of post-transplant methotrexate, cyclosporin A and prednisolone on graft rejection after allogeneic bone marrow transplantation.
Topics: Administration, Oral; Animals; Bone Marrow Transplantation; Cyclosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Graft Rejection; Graft vs Host Disease; Immunosuppression Therapy; Injections, Intraperitoneal; Methotrexate; Prednisolone; Rats; Rats, Inbred Lew; Whole-Body Irradiation | 1991 |
Effect of the immune modulating agents cyclophosphamide, methotrexate, hydrocortisone, and cyclosporin A on an animal model of granulomatous bowel disease.
Topics: Adjuvants, Immunologic; Animals; Cyclophosphamide; Cyclosporins; Disease Models, Animal; Female; Granuloma; Guinea Pigs; Hydrocortisone; Ileal Diseases; Lymph Nodes; Methotrexate; Organ Size | 1990 |
Effect of concentration and time of drug exposure on clonal growth of murine bladder cancer.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cell Line; Cisplatin; Colony-Forming Units Assay; Disease Models, Animal; Doxorubicin; FANFT; Female; Fluorouracil; Maytansine; Methotrexate; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Podophyllotoxin; Streptozocin; Time Factors; Trichothecenes; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1985 |
Methotrexate in rheumatoid arthritis: studies with animal models.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Chemotaxis, Leukocyte; Disease Models, Animal; Female; Histocompatibility Antigens Class II; Interleukin-1; Interleukin-2; Male; Methotrexate; Neutrophils; Rats; Rats, Inbred Lew; Spleen | 1989 |
Experimental study on subacute neurotoxicity of methotrexate in cats.
Topics: Animals; Cats; Cerebrospinal Fluid; Demyelinating Diseases; Disease Models, Animal; Drug Synergism; Female; Male; Methotrexate; Necrosis; Neurotoxins; Risk Factors | 1989 |
An animal model to detect the neuropsychological toxicity of anticancer agents.
Topics: Animals; Avoidance Learning; Brain; Cognition; Conditioning, Classical; Disease Models, Animal; Female; Learning; Male; Methotrexate; Rats; Rats, Inbred Lew; Taste | 1989 |
New xenograft model for assessing experimental therapy of central nervous system tumors: human glioblastoma in the intrathecal compartment of the nude mouse.
Topics: Animals; Carmustine; Cell Line; Disease Models, Animal; Drug Screening Assays, Antitumor; Glioma; Humans; Injections, Intraperitoneal; Injections, Spinal; Male; Methotrexate; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplasms, Nerve Tissue; Spinal Cord; Time Factors; Transplantation, Heterologous | 1988 |
Induction of hepatic veno-occlusive disease in dogs.
Topics: Animals; Busulfan; Buthionine Sulfoximine; Cyclophosphamide; Disease Models, Animal; Dog Diseases; Dogs; Hepatic Veno-Occlusive Disease; Liver; Melphalan; Methionine Sulfoximine; Methotrexate; Monocrotaline; Pyrrolizidine Alkaloids; Radiation Injuries, Experimental; Radiography | 1987 |
Studies on the effect of D-penicillamine, gold thioglucose and methotrexate on streptococcal cell wall arthritis.
Topics: Animals; Arthritis, Infectious; Aurothioglucose; Cell Wall; Concanavalin A; Disease Models, Animal; Female; Gold; Interleukin-2; Methotrexate; Penicillamine; Rats; Rats, Inbred Lew; Spleen; Streptococcal Infections | 1986 |
Preclinical trials using an immunoconjugate of T101 and methotrexate in an athymic mouse/human T-cell tumor model.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Disease Models, Animal; Humans; Immunotoxins; Methotrexate; Mice; Mice, Nude; Neoplasms, Experimental | 1988 |
T lymphocyte line-mediated experimental allergic encephalomyelitis--a pharmacologic model for testing of immunosuppressive agents for the treatment of autoimmune central nervous system disease.
Topics: Animals; Autoimmune Diseases; Cell Line; Central Nervous System Diseases; Disease Models, Animal; Drug Tolerance; Encephalomyelitis; Female; Immunosuppressive Agents; Injections, Intraperitoneal; Injections, Intravenous; Methotrexate; Rats; Rats, Inbred Lew; T-Lymphocytes | 1987 |
A preliminary report on the suitability of sheep epidermal squamous cell carcinoma as a solid tumor model in the evaluation of intra-arterial methotrexate administration.
Topics: Animals; Carcinoma, Squamous Cell; Disease Models, Animal; DNA, Neoplasm; Epidermis; Flow Cytometry; Head and Neck Neoplasms; Infusions, Intra-Arterial; Infusions, Parenteral; Methotrexate; Neoplasm Staging; Sheep; Skin Neoplasms | 1986 |
The effect of low dose chronic intermittent parental methotrexate on delayed type hypersensitivity and acute inflammation in a mouse model.
Topics: Animals; Arthritis, Rheumatoid; Disease Models, Animal; Female; Hypersensitivity, Delayed; Immunosuppression Therapy; Inflammation; Methotrexate; Mice; Mice, Inbred BALB C; Time Factors | 1986 |
Nb rat prostate adenocarcinoma model: evaluation of the subrenal capsular assay system.
Topics: Adenocarcinoma; Animals; Cisplatin; Cyclophosphamide; Disease Models, Animal; Doxorubicin; Histological Techniques; Kidney Neoplasms; Male; Methotrexate; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rats, Inbred Strains | 1985 |
A two-stage therapeutic design in the spontaneous AKR lymphoma system.
Topics: Amides; Animals; Antineoplastic Agents; Azacitidine; Cyclic P-Oxides; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Female; Imidazoles; Lymphoma; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred Strains; Oxazines; Prednisone; Remission, Spontaneous; Time Factors; Triazenes; Vincristine | 1972 |
In vitro studies of the cell-bound and antibody-mediated immunity evoked by murine renal allotransplants. Influence of presensitization, total body irradiation and immunosuppressive agents.
Topics: Animals; Antibody Formation; Antilymphocyte Serum; Azathioprine; Cells, Cultured; Dactinomycin; Disease Models, Animal; Female; Hot Temperature; Immunity, Cellular; Immunosuppressive Agents; Kidney; Kidney Transplantation; Leucovorin; Male; Methotrexate; Methylprednisolone; Radiation Effects; Rats; Thoracic Duct; Transplantation Immunology | 1973 |
Intra-arterial infusion chemotherapy in head and neck cancer. A clinical and experimental study.
Topics: Animals; Carotid Artery, External; Catheterization; Chemotherapy, Cancer, Regional Perfusion; Disease Models, Animal; Drug Therapy, Combination; Fluorouracil; Follow-Up Studies; Head; Head and Neck Neoplasms; Humans; Methods; Methotrexate; Neoplasms; Rats; Rhabdomyosarcoma; Staining and Labeling | 1973 |
Potentially useful combinations of chemotherapy detected in mouse tumor systems.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Azauridine; Bleomycin; Camptothecin; Cyclic P-Oxides; Cyclophosphamide; Cytarabine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethylamines; Fluorouracil; Imidazoles; Leukemia L1210; Lung Neoplasms; Methotrexate; Mice; Neoplasms, Experimental; Oxazines; Piperazines; Procarbazine; Propane; Triazenes | 1974 |
Haematological effects of chronic ethanol administration and folic acid deficiency in mice.
Topics: Alcoholic Intoxication; Anemia; Animals; Disease Models, Animal; Folic Acid Deficiency; Hematopoiesis; Humans; Male; Methotrexate; Mice | 1973 |
The growth of human tumours in immunosuppressed mice and their response to chemotherapy.
Topics: Animals; Chlorambucil; Cyclophosphamide; Dactinomycin; Disease Models, Animal; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Immunosuppression Therapy; Male; Melphalan; Methotrexate; Mice; Mice, Inbred CBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Thiotepa; Thymectomy; Transplantation, Heterologous; Triaziquone; Urinary Bladder Neoplasms; Vinblastine; Vincristine | 1974 |
Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cyclophosphamide; Disease Models, Animal; Ependymoma; Evaluation Studies as Topic; Fluorouracil; Glioma; Injections, Intraperitoneal; Male; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitroso Compounds; Nitrosourea Compounds; Plicamycin; Urea; Vincristine | 1971 |
Current trends in the chemotherapy of brain tumors with special reference to glioblastomas.
Topics: Alkaloids; Antibiotics, Antineoplastic; Antineoplastic Agents; Azaguanine; Blood Vessel Prosthesis; Blood-Brain Barrier; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cell Transformation, Neoplastic; Disease Models, Animal; Fluorouracil; Glioblastoma; Humans; Injections, Intra-Arterial; Injections, Spinal; Mechlorethamine; Methotrexate; Nitroso Compounds; Thiotepa; Time Factors; Urea; Vincristine | 1969 |
The effect of methotrexate and dactinomycin on transplantable malignant and benign trophoblastic growths.
Topics: Animals; Cheek; Choriocarcinoma; Cricetinae; Dactinomycin; Disease Models, Animal; Drug Synergism; Female; Humans; Methotrexate; Neoplasm Transplantation; Neoplasms, Experimental; Pregnancy; Trophoblastic Neoplasms | 1970 |
A re-examination of the renal blastema graft model for Wilms tumor production.
Topics: Animals; Autopsy; Cell Differentiation; Cyclophosphamide; Dactinomycin; Disease Models, Animal; Drug Therapy, Combination; Female; Fetus; Fluorouracil; Kidney; Kidney Neoplasms; Kidney Transplantation; Male; Methotrexate; Mice; Mice, Inbred Strains; Microscopy, Electron; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Pregnancy; Testicular Neoplasms; Transplantation, Homologous; Vincristine; Wilms Tumor | 1974 |
ICRF-159 in treatment of germinal testicular tumor in animals.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Disease Models, Animal; Dogs; Drug Therapy, Combination; Fluorouracil; Male; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Piperazines; Propane; Teratoma; Testicular Neoplasms; Vincristine | 1974 |
Combination chemotherapy for spontaneous AKR lymphoma.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Lymphoma; Methotrexate; Mice; Mice, Inbred AKR; Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Palmitic Acids; Prednisone; Remission, Spontaneous; Rodent Diseases; Spleen; Splenomegaly; Thymus Gland; Time Factors; Vincristine | 1974 |
Attempts at immunotherapy of 100 patients with acute lymphoid leukemia: some factors influencing results.
Topics: Animals; Bone Marrow Examination; Central Nervous System; Corynebacterium; Cytarabine; Cytotoxicity Tests, Immunologic; Disease Models, Animal; Female; Humans; Immune Sera; Immunotherapy; Leukemia, Experimental; Leukemia, Lymphoid; Lymphocyte Activation; Male; Methotrexate; Mice; Mice, Inbred AKR; Remission, Spontaneous | 1972 |
Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Cyclophosphamide; Diethylamines; Disease Models, Animal; Drug Therapy, Combination; Ethylenediamines; Fluorenes; Fluorouracil; Interferon Inducers; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Prednisolone; Thioxanthenes; Vincristine | 1974 |
Keynote address on chemotherapy for lung cancer.
Topics: Alkylating Agents; Carcinoma; Cyclophosphamide; Disease Models, Animal; Humans; Lung Neoplasms; Methotrexate; Nitrosourea Compounds; Research | 1973 |
[Leukemia L 5222 of the rat strain BD IX. An ethylnitrosourea-induced monocytic-myeloic transplantable form for cytochemical and chemotherapeutic studies].
Topics: Alkaline Phosphatase; Animals; Cell Transformation, Neoplastic; Cyclophosphamide; Disease Models, Animal; Esterases; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Leukemia, Experimental; Liver; Lymph Nodes; Mercaptopurine; Methotrexate; Neoplasm Transplantation; Nitrosourea Compounds; Peroxidases; Rats; Rats, Inbred Strains; Spleen; Transplantation, Homologous; Vincristine | 1974 |
The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Bone Marrow; Brain; Brain Neoplasms; Carbon Isotopes; Carmustine; Cyclohexanes; Cytarabine; Deoxyuridine; Disease Models, Animal; DNA, Neoplasm; Dose-Response Relationship, Drug; Ependymoma; Glioma; Lymph Nodes; Male; Methotrexate; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Thymidine; Tritium | 1972 |
Adjuvant-induced arthritis in rats. II. Drug effects on physiologic, biochemical and immunologic parameters.
Topics: Animals; Anti-Inflammatory Agents; Antibodies; Arthritis; Aspirin; Body Weight; Cyclophosphamide; Disease Models, Animal; Freund's Adjuvant; Hindlimb; Immunosuppressive Agents; Indomethacin; Male; Methotrexate; Muramidase; Phenylbutazone; Prednisolone; Rats | 1971 |
Resistance of Chinese hamsters to Hymenolepis microstoma and its reversal by immunosuppression.
Topics: Abdominal Neoplasms; Animals; Bile Ducts; Cestoda; Cricetinae; Disease Models, Animal; Duodenum; Female; Freund's Adjuvant; Granuloma; Hymenolepiasis; Hypertrophy; Immunosuppression Therapy; Injections, Intraperitoneal; Larva; Male; Methotrexate; Mice; Ovum; Pancreas; Time Factors | 1971 |
The treatment of acute lymphocytic leukemia.
Topics: Animals; Antineoplastic Agents; Asparaginase; Blood Platelets; Bone Marrow Cells; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Synergism; Hemorrhage; Humans; Infections; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Mice; Prednisone; Prognosis; Thrombocytopenia; Vincristine | 1970 |
Therapy of acute leukemia.
Topics: Adolescent; Animals; Antineoplastic Agents; Asparaginase; Bone Marrow; Bone Marrow Cells; Child; Cytarabine; Daunorubicin; Disease Models, Animal; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Mice; Remission, Spontaneous; Vincristine | 1970 |
Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative.
Topics: Amides; Animals; Azathioprine; Cyclophosphamide; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Imidazoles; Immunosuppressive Agents; Methotrexate; Nitrogen Mustard Compounds; Rats | 1969 |
The effect of chemotherapy on germinal testicular tumors in mice.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Disease Models, Animal; Female; Fluorouracil; Male; Methotrexate; Mice; Neoplasm Transplantation; Teratoma; Testicular Neoplasms; Time Factors; Vincristine | 1970 |
Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
Topics: Animals; Antibiotics, Antineoplastic; Blood-Brain Barrier; Brain Neoplasms; Cyclophosphamide; Disease Models, Animal; Ependymoma; Glioma; Injections; Male; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitroso Compounds; Statistics as Topic; Urea | 1970 |
Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Disease Models, Animal; DNA, Neoplasm; Fluorouracil; Half-Life; Hydroxyurea; In Vitro Techniques; Kinetics; Leukemia L1210; Mercaptopurine; Methotrexate; Mice; Mitosis; Nitrosourea Compounds; Thiosemicarbazones | 1970 |
Effects of hormones, methotrexate, and dactinomycin on benign trophoblast.
Topics: Animals; Chorionic Gonadotropin; Cricetinae; Dactinomycin; Disease Models, Animal; Estradiol; Methotrexate; Placenta; Progesterone; Transplantation, Heterologous; Trophoblasts | 1971 |
Differential effects of anti-tumour drugs on human tumour and spleen DNA synthesis in vitro.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Culture Techniques; Disease Models, Animal; DNA; Fluorouracil; Melphalan; Methotrexate; Mice; Spleen | 1971 |